The	O
role	O
of	O
NF-kappa	B-DNA
B1	I-DNA
(	I-DNA
p50/p105	I-DNA
)	I-DNA
gene	I-DNA
expression	O
in	O
activation	O
of	O
human	B-cell_type
blood	I-cell_type
T-lymphocytes	I-cell_type
via	O
CD2	B-protein
and	I-protein
CD28	I-protein
adhesion	I-protein
molecules	I-protein
.	O

Stimulation	O
of	O
primary	B-cell_type
human	I-cell_type
T-lymphocytes	I-cell_type
via	O
CD2	B-protein
and	I-protein
CD28	I-protein
adhesion	I-protein
molecules	I-protein
induces	O
a	O
long-lasting	O
proliferation	O
(	O
>	O
3	O
weeks	O
)	O
.	O

This	O
potent	O
activation	O
does	O
not	O
require	O
accessory	O
cells	O
,	O
such	O
as	O
monocytes	B-cell_type
,	O
but	O
depends	O
on	O
persistent	O
interleukin	B-protein
2	I-protein
(	O
IL-2	B-protein
)	O
secretion	O
and	O
receptivity	O
,	O
which	O
is	O
associated	O
with	O
high	O
and	O
prolonged	O
expression	O
of	O
the	O
inducible	O
CD25/IL-2	B-DNA
receptor	I-DNA
alpha	I-DNA
(	I-DNA
IL-2R	I-DNA
alpha	I-DNA
)	I-DNA
chain	I-DNA
gene	I-DNA
.	O

The	O
transcription	B-protein
factor	I-protein
NF-kappa	I-protein
B	I-protein
participates	O
in	O
the	O
regulation	O
of	O
both	O
IL-2	B-DNA
and	I-DNA
IL-2R	I-DNA
alpha	I-DNA
genes	I-DNA
,	O
as	O
well	O
as	O
multiple	B-DNA
cellular	I-DNA
genes	I-DNA
involved	O
in	O
T-cell	O
proliferation	O
.	O

To	O
evaluate	O
the	O
role	O
of	O
NF-kappa	B-protein
B	I-protein
in	O
human	B-cell_type
peripheral	I-cell_type
blood	I-cell_type
T-lymphocytes	I-cell_type
,	O
we	O
previously	O
analyzed	O
the	O
activation	O
of	O
NF-kappa	B-protein
B-related	I-protein
complexes	I-protein
in	O
response	O
to	O
CD2+CD28	O
costimulation	O
.	O

We	O
demonstrated	O
a	O
long-term	O
induction	O
of	O
p50/p65	B-protein
heterodimer	I-protein
,	O
a	O
putative	B-protein
p65/c-Rel	I-protein
heterodimer	I-protein
,	O
and	O
a	O
constitutive	O
nuclear	O
expression	O
of	O
KBF1/p50	B-protein
homodimers	I-protein
.	I-protein

As	O
the	O
role	O
of	O
p50	B-protein
remains	O
unclear	O
,	O
we	O
focused	O
our	O
present	O
study	O
on	O
NF-kappa	B-protein
B1	I-protein
(	O
p50/p105	B-protein
)	O
gene	O
regulation	O
.	O

Using	O
electrophoretic	O
mobility	O
shift	O
assays	O
and	O
Western	O
and	O
Northern	O
blot	O
analyses	O
,	O
we	O
studied	O
NF-kappa	B-DNA
B1	I-DNA
gene	I-DNA
expression	O
during	O
T-cell	O
stimulation	O
via	O
CD2+CD28	B-protein
.	O

We	O
observed	O
a	O
transient	O
4-	O
to	O
5-fold	O
increase	O
of	O
NF-kappa	O
B1	O
gene	O
expression	O
at	O
both	O
the	O
mRNA	O
and	O
protein	O
levels	O
,	O
lasting	O
for	O
at	O
least	O
24	O
h	O
.	O

p50	O
DNA-binding	O
activity	O
apparently	O
stays	O
highly	O
controlled	O
when	O
p105	O
expression	O
is	O
enhanced	O
by	O
a	O
physiological	O
stimulus	O
of	O
peripheral	B-cell_type
blood	I-cell_type
T-cells	I-cell_type
.	O

Partial	O
inhibition	O
of	O
p50	O
and	O
p105	O
expression	O
by	O
NF-kappa	B-protein
B1	I-protein
antisense	O
oligonucleotides	O
significantly	O
reduced	O
T-cell	O
proliferation	O
and	O
CD25/IL-2R	B-protein
alpha	I-protein
cell	O
surface	O
expression	O
.	O

(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O

Vol	NULL
.	NULL

4	NULL
,	NULL
947-954	NULL
,	NULL
November	NULL
1993	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
The	NULL
Role	NULL
of	NULL
NF-	NULL
«	NULL
BI1	NULL
(	NULL
p50/p105	NULL
)	NULL
Gene	NULL
Expression	NULL
in	NULL
Activation	NULL
of	NULL
Human	NULL
Blood	NULL
T-Lymphocytes	NULL
via	NULL
CD2	NULL
and	NULL
CD28	NULL
Adhesion	NULL
Molecules	NULL
!	NULL

Régis	NULL
Costello	NULL
,	NULL
Chantal	NULL
Cerdan	NULL
,	NULL
Carol	NULL
Lipcey	NULL
,	NULL
Michéle	NULL
Algarté	NULL
,	NULL
Yves	NULL
Martin	NULL
,	NULL
Patrick	NULL
A.	NULL
Baeuerle	NULL
,	NULL
Daniel	NULL
Olive	NULL
,	NULL
and	NULL
Jean	NULL
Imbert®	NULL
Unité	NULL
119	NULL
,	NULL
Institut	NULL
National	NULL
de	NULL
la	NULL
Santé	NULL
et	NULL
de	NULL
la	NULL
Recherche	NULL
Médicale	NULL
,	NULL
27	NULL
,	NULL
Boulevard	NULL
Lei	NULL
Roure	NULL
,	NULL
13009	NULL
Marseille	NULL
,	NULL
France	NULL
[	NULL
R.	NULL
C.	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Y.	NULL
M.	NULL
,	NULL
D.	NULL
O.	NULL
,	NULL
J.	NULL
L1	NULL
,	NULL
and	NULL
Laboratorium	NULL
fiir	NULL
Molekulare	NULL
Biologie	NULL
,	NULL
Ludwig-Maximilians-Universitat	NULL
,	NULL
Genzentrum	NULL
,	NULL
D-8033	NULL
Martinsried	NULL
,	NULL
Germany	NULL
[	NULL
P.	NULL
A	NULL
.	NULL

B	NULL
.	NULL
]	NULL

Abstract	NULL
Stimulation	NULL
of	NULL
primary	NULL
human	NULL
T-lymphocytes	NULL
via	NULL
CD2	NULL
and	NULL
CD28	NULL
adhesion	NULL
molecules	NULL
induces	NULL
a	NULL
long-lasting	NULL
proliferation	NULL
(	NULL
>	NULL
3	NULL
weeks	NULL
)	NULL
.	NULL

This	NULL
potent	NULL
activation	NULL
does	NULL
not	NULL
require	NULL
accessory	NULL
cells	NULL
,	NULL
such	NULL
as	NULL
monocytes	NULL
,	NULL
but	NULL
depends	NULL
on	NULL
persistent	NULL
interleukin	NULL
2	NULL
(	NULL
IL-2	NULL
)	NULL
secretion	NULL
and	NULL
receptivity	NULL
,	NULL
which	NULL
is	NULL
associated	NULL
with	NULL
high	NULL
and	NULL
prolonged	NULL
expression	NULL
of	NULL
the	NULL
inducible	NULL
CD25/IL-2	NULL
receptor	NULL
a	NULL
(	NULL
IL-2Ra	NULL
)	NULL
chain	NULL
gene	NULL
.	NULL

The	NULL
transcription	NULL
factor	NULL
NF-KB	NULL
participates	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
both	NULL
IL-2	NULL
and	NULL
/L-2Ra	NULL
genes	NULL
,	NULL
as	NULL
well	NULL
as	NULL
multiple	NULL
cellular	NULL
genes	NULL
involved	NULL
in	NULL
T-cell	NULL
proliferation	NULL
.	NULL

To	NULL
evaluate	NULL
the	NULL
role	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
human	NULL
peripheral	NULL
blood	NULL
T-lymphocytes	NULL
,	NULL
we	NULL
previously	NULL
analyzed	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B-related	NULL
complexes	NULL
in	NULL
response	NULL
to	NULL
CD2+CD28	NULL
costimulation	NULL
.	NULL

We	NULL
demonstrated	NULL
a	NULL
long-term	NULL
induction	NULL
of	NULL
p50/p65	NULL
heterodimer	NULL
,	NULL
a	NULL
putative	NULL
p65/c-Rel	NULL
heterodimer	NULL
,	NULL
and	NULL
a	NULL
constitutive	NULL
nuclear	NULL
expression	NULL
of	NULL
KBF1/p50	NULL
homodimers	NULL
.	NULL

As	NULL
the	NULL
role	NULL
of	NULL
p50	NULL
remains	NULL
unclear	NULL
,	NULL
we	NULL
focused	NULL
our	NULL
present	NULL
study	NULL
on	NULL
NF-	NULL
«	NULL
B1	NULL
(	NULL
p50/p105	NULL
)	NULL
gene	NULL
regulation	NULL
.	NULL

Using	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
and	NULL
Western	NULL
and	NULL
Northern	NULL
blot	NULL
analyses	NULL
,	NULL
we	NULL
studied	NULL
NF-	NULL
«	NULL
B1	NULL
gene	NULL
expression	NULL
during	NULL
T-cell	NULL
stimulation	NULL
via	NULL
CD2+CD28	NULL
.	NULL

We	NULL
observed	NULL
a	NULL
transient	NULL
4-	NULL
to	NULL
5-fold	NULL
increase	NULL
of	NULL
NF-	NULL
«	NULL
BI1	NULL
gene	NULL
expression	NULL
at	NULL
both	NULL
the	NULL
mRNA	NULL
and	NULL
protein	NULL
levels	NULL
,	NULL
lasting	NULL
for	NULL
at	NULL
least	NULL
24	NULL
h.	NULL
p50	NULL
DNA-binding	NULL
activity	NULL
apparently	NULL
stays	NULL
highly	NULL
controlled	NULL
when	NULL
p105	NULL
expression	NULL
is	NULL
enhanced	NULL
by	NULL
a	NULL
physiological	NULL
stimulus	NULL
of	NULL
peripheral	NULL
blood	NULL
T-cells	NULL
.	NULL

Partial	NULL
inhibition	NULL
of	NULL
p50	NULL
and	NULL
p105	NULL
expression	NULL
by	NULL
NF-B1	NULL
antisense	NULL
oligonucleotides	NULL
significantly	NULL
reduced	NULL
T-cell	NULL
proliferation	NULL
and	NULL
CD25/IL-2Ra	NULL
cell	NULL
surface	NULL
expression	NULL
.	NULL

These	NULL
data	NULL
provide	NULL
direct	NULL
evidence	NULL
for	NULL
a	NULL
role	NULL
of	NULL
NF-	NULL
«	NULL
BI1	NULL
gene	NULL
positive	NULL
regulation	NULL
during	NULL
CD2+CD28	NULL
stimulation	NULL
of	NULL
primary	NULL
human	NULL
T-cells	NULL
.	NULL

Received	NULL
7/8/93	NULL
;	NULL
revised	NULL
8/16/93	NULL
;	NULL
accepted	NULL
9/8/93	NULL
.	NULL
'	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
Institut	NULL
National	NULL
de	NULL
la	NULL
Santé	NULL
et	NULL
de	NULL
la	NULL
Recherche	NULL
Médicale	NULL
and	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
Association	NULL
pour	NULL
la	NULL
Recherche	NULL
sur	NULL
le	NULL
Cancer	NULL
,	NULL
awarded	NULL
to	NULL
J.	NULL
Imbert	NULL
and	NULL
D.	NULL
Olive	NULL
,	NULL
and	NULL
partially	NULL
fulfills	NULL
the	NULL
requirements	NULL
for	NULL
the	NULL
doctoral	NULL
thesis	NULL
of	NULL
R.	NULL
Costello	NULL
and	NULL
M.	NULL
Algarté	NULL
.	NULL

2	NULL
To	NULL
whom	NULL
requests	NULL
for	NULL
reprints	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

Introduction	NULL
In	NULL
vitro	NULL
,	NULL
T-lymphocyte	NULL
activation	NULL
requires	NULL
two	NULL
signals	NULL
provided	NULL
by	NULL
different	NULL
combinations	NULL
of	NULL
stimuli	NULL
such	NULL
as	NULL
lectins	NULL
,	NULL
phorbol	NULL
!	NULL

esters	NULL
,	NULL
cytokines	NULL
,	NULL
or	NULL
mAbs	NULL
.	NULL

Two	NULL
main	NULL
activation	NULL
pathways	NULL
have	NULL
been	NULL
described	NULL
:	NULL
the	NULL
antigen-dependent	NULL
pathway	NULL
,	NULL
involving	NULL
the	NULL
CD3/TcR	NULL
complex	NULL
,	NULL
and	NULL
the	NULL
alternate	NULL
pathway	NULL
,	NULL
engaging	NULL
adhesion	NULL
molecules	NULL
such	NULL
as	NULL
CD2	NULL
and	NULL
CD28	NULL
.	NULL

CD2	NULL
is	NULL
present	NULL
on	NULL
nearly	NULL
all	NULL
T-lymphocytes	NULL
.	NULL

CD28	NULL
is	NULL
present	NULL
on	NULL
only	NULL
half	NULL
of	NULL
the	NULL
CD8-positive	NULL
T-cells	NULL
,	NULL
but	NULL
on	NULL
almost	NULL
all	NULL
of	NULL
the	NULL
CD4-positive	NULL
cells	NULL
(	NULL
1	NULL
)	NULL
.	NULL

These	NULL
molecules	NULL
have	NULL
several	NULL
functional	NULL
ligands	NULL
in	NULL
vivo	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
B7/BB1	NULL
for	NULL
CD28	NULL
(	NULL
2	NULL
,	NULL
3	NULL
)	NULL
,	NULL
and	NULL
LFA-3/COS58	NULL
(	NULL
4-6	NULL
)	NULL
,	NULL
CD59	NULL
(	NULL
7	NULL
)	NULL
,	NULL
and	NULL
CD48	NULL
(	NULL
8	NULL
)	NULL
for	NULL
CD2	NULL
.	NULL

Costimulation	NULL
of	NULL
CD2	NULL
and	NULL
CD28	NULL
is	NULL
an	NULL
excellent	NULL
model	NULL
for	NULL
in	NULL
vitro	NULL
study	NULL
of	NULL
antigen-independent	NULL
T-lymphocyte	NULL
activation	NULL
.	NULL

Their	NULL
simultaneous	NULL
activation	NULL
leads	NULL
to	NULL
a	NULL
long-lasting	NULL
proliferation	NULL
(	NULL
>	NULL
3	NULL
weeks	NULL
versus	NULL
10	NULL
days	NULL
for	NULL
CD3/TcR-mediated	NULL
activation	NULL
)	NULL
of	NULL
highly	NULL
purified	NULL
human	NULL
T-lymphocytes	NULL
(	NULL
9	NULL
)	NULL
,	NULL
which	NULL
depends	NULL
on	NULL
their	NULL
IL-2	NULL
secretion	NULL
via	NULL
a	NULL
paracrine/autocrine	NULL
pathway	NULL
(	NULL
10-12	NULL
)	NULL
.	NULL

This	NULL
long-term	NULL
IL-2	NULL
receptivity	NULL
is	NULL
supported	NULL
by	NULL
a	NULL
persistent	NULL
high-level	NULL
expression	NULL
of	NULL
at	NULL
least	NULL
both	NULL
IL-2	NULL
receptor	NULL
a	NULL
and	NULL
B	NULL
chains	NULL
(	NULL
9	NULL
,	NULL
13-15	NULL
)	NULL
.	NULL

T-cell	NULL
stimulation	NULL
leads	NULL
to	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
participates	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
multiple	NULL
genes	NULL
involved	NULL
in	NULL
immune	NULL
,	NULL
acute	NULL
phase	NULL
,	NULL
and	NULL
inflammatory	NULL
responses	NULL
,	NULL
including	NULL
the	NULL
genes	NULL
encoding	NULL
for	NULL
IL-2Ra	NULL
,	NULL
IL-2	NULL
,	NULL
and	NULL
other	NULL
lymphokines	NULL
(	NULL
for	NULL
a	NULL
review	NULL
,	NULL
see	NULL
Ref	NULL
.	NULL

16	NULL
)	NULL
.	NULL

In	NULL
resting	NULL
T-cells	NULL
,	NULL
the	NULL
NF-kB	NULL
complex	NULL
,	NULL
composed	NULL
of	NULL
50-	NULL
and	NULL
65-kDa	NULL
subunits	NULL
,	NULL
is	NULL
sequestered	NULL
in	NULL
the	NULL
cytoplasm	NULL
as	NULL
an	NULL
inactive	NULL
precursor	NULL
complexed	NULL
with	NULL
an	NULL
inhibitory	NULL
protein	NULL
,	NULL
IB	NULL
(	NULL
17	NULL
,	NULL
18	NULL
)	NULL
.	NULL

Nuclear	NULL
translocation	NULL
of	NULL
the	NULL
active	NULL
form	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
19	NULL
)	NULL
is	NULL
posttranslationally	NULL
induced	NULL
by	NULL
various	NULL
stimuli	NULL
including	NULL
CD2	NULL
and	NULL
CD28	NULL
.	NULL

Both	NULL
subunits	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
p50	NULL
and	NULL
p65	NULL
,	NULL
bind	NULL
to	NULL
DNA	NULL
(	NULL
20	NULL
)	NULL
.	NULL

p50	NULL
is	NULL
most	NULL
probably	NULL
the	NULL
NH	NULL
-terminal	NULL
half	NULL
of	NULL
a	NULL
larger	NULL
protein	NULL
,	NULL
p105	NULL
,	NULL
proteolytically	NULL
processed	NULL
to	NULL
its	NULL
functional	NULL
size	NULL
(	NULL
21-24	NULL
)	NULL
.	NULL

This	NULL
can	NULL
be	NULL
mimicked	NULL
by	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
1	NULL
protease	NULL
during	NULL
acute	NULL
infection	NULL
(	NULL
23	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
its	NULL
precursor	NULL
role	NULL
,	NULL
p105	NULL
possesses	NULL
an	NULL
IkB-like	NULL
activity	NULL
(	NULL
25	NULL
,	NULL
26	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
BI	NULL
gene	NULL
is	NULL
a	NULL
member	NULL
of	NULL
a	NULL
transcription	NULL
factor	NULL
gene	NULL
family	NULL
,	NULL
including	NULL
the	NULL
two	NULL
NF-	NULL
«	NULL
B	NULL
subunits	NULL
p50	NULL
and	NULL
p65	NULL
,	NULL
c-Rel	NULL
,	NULL
p49/p100	NULL
,	NULL
and	NULL
I-Rel	NULL
(	NULL
for	NULL
re-views	NULL
,	NULL
see	NULL
Refs	NULL
.	NULL

27	NULL
and	NULL
28	NULL
)	NULL
.	NULL

Distinct	NULL
combinations	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
subunits	NULL
can	NULL
determine	NULL
the	NULL
specificity	NULL
of	NULL
transcriptional	NULL
activation	NULL
through	NULL
modulation	NULL
of	NULL
binding	NULL
to	NULL
the	NULL
various	NULL
B	NULL
motifs	NULL
(	NULL
27	NULL
,	NULL
29-31	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
a	NULL
wealth	NULL
of	NULL
information	NULL
on	NULL
rel/NF-	NULL
«	NULL
B	NULL
gene	NULL
family	NULL
structure	NULL
and	NULL
interaction	NULL
with	NULL
IkB	NULL
and	NULL
«	NULL
B	NULL
enhancer	NULL
*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
mAb	NULL
,	NULL
monoclonal	NULL
antibody	NULL
;	NULL
IL-2	NULL
,	NULL
interleukin	NULL
2	NULL
;	NULL
-R	NULL
,	NULL
receptor	NULL
;	NULL
kDa	NULL
,	NULL
kilodalton	NULL
(	NULL
s	NULL
)	NULL
;	NULL
kb	NULL
,	NULL
kilobase	NULL
(	NULL
s	NULL
)	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
ECL	NULL
,	NULL
enhanced	NULL
chemiluminescence	NULL
;	NULL
cDNA	NULL
,	NULL
complementary	NULL
DNA	NULL
;	NULL
HuB	NULL
;	NULL
m	NULL
,	NULL
human	NULL
B	NULL
,	NULL
-microglobulin	NULL
;	NULL
SSC	NULL
,	NULL
standard	NULL
saline	NULL
citrate	NULL
;	NULL
SDS	NULL
,	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
;	NULL
CMV	NULL
,	NULL
cytomegalovirus	NULL
;	NULL
Hepes	NULL
,	NULL
4-	NULL
(	NULL
2-hydroxyethyl	NULL
)	NULL
-1-piperazineethanesulfonic	NULL
|	NULL
acid	NULL
;	NULL
MTT	NULL
,	NULL
-	NULL
3-	NULL
(	NULL
4,5-dimethylthiazol-2-y1	NULL
)	NULL
-2,5-diphenyl	NULL
tetrazolium	NULL
bromide	NULL
.	NULL

Role	NULL
of	NULL
NF-	NULL
«	NULL
B1	NULL
Gene	NULL
in	NULL
CD2+CD28	NULL
Activation	NULL
elements	NULL
,	NULL
only	NULL
a	NULL
few	NULL
studies	NULL
have	NULL
attempted	NULL
to	NULL
assess	NULL
its	NULL
physiological	NULL
role	NULL
in	NULL
human	NULL
peripheral	NULL
blood	NULL
T-cells	NULL
(	NULL
32-36	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
role	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
T-lymphocytes	NULL
was	NULL
mainly	NULL
studied	NULL
in	NULL
the	NULL
tumor	NULL
model	NULL
and	NULL
in	NULL
T-cell	NULL
clones	NULL
which	NULL
exhibit	NULL
biological	NULL
characteristics	NULL
such	NULL
as	NULL
cytokine	NULL
secretion	NULL
and	NULL
responses	NULL
that	NULL
are	NULL
not	NULL
manifested	NULL
by	NULL
primary	NULL
T-lymphocytes	NULL
(	NULL
37-42	NULL
)	NULL
.	NULL

In	NULL
an	NULL
attempt	NULL
to	NULL
understand	NULL
the	NULL
physiological	NULL
role	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
we	NULL
recently	NULL
reported	NULL
that	NULL
CD2+CD28	NULL
stimulation	NULL
of	NULL
purified	NULL
human	NULL
T-cells	NULL
is	NULL
associated	NULL
with	NULL
long-term	NULL
persistence	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
two	NULL
inducible	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
and	NULL
of	NULL
constitutive	NULL
KBF1/p50	NULL
homodimers	NULL
(	NULL
43	NULL
)	NULL
.	NULL

The	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
nuclear	NULL
activation	NULL
by	NULL
the	NULL
free	NULL
radical	NULL
scavenger	NULL
pyrrolidine	NULL
dithiocarbamate	NULL
was	NULL
associated	NULL
with	NULL
inhibition	NULL
of	NULL
T-cell	NULL
proliferation	NULL
and	NULL
IL-2	NULL
secretion	NULL
.	NULL

These	NULL
data	NULL
suggested	NULL
that	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
its	NULL
well-known	NULL
involvement	NULL
in	NULL
the	NULL
immediate	NULL
response	NULL
to	NULL
external	NULL
stimuli	NULL
(	NULL
for	NULL
a	NULL
review	NULL
,	NULL
see	NULL
Ref	NULL
.	NULL

16	NULL
)	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
could	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
maintenance	NULL
of	NULL
T-cell	NULL
activation	NULL
via	NULL
CD2	NULL
and	NULL
CD28	NULL
.	NULL

The	NULL
emerging	NULL
multifunctional	NULL
role	NULL
of	NULL
p50	NULL
and	NULL
its	NULL
precursor	NULL
p105	NULL
(	NULL
26	NULL
,	NULL
44	NULL
)	NULL
prompted	NULL
us	NULL
to	NULL
focus	NULL
the	NULL
present	NULL
study	NULL
on	NULL
NF-	NULL
«	NULL
B1	NULL
gene	NULL
regulation	NULL
during	NULL
activation	NULL
of	NULL
primary	NULL
human	NULL
T-cells	NULL
through	NULL
the	NULL
adhesion	NULL
molecule	NULL
pathway	NULL
.	NULL

Results	NULL
NF-	NULL
«	NULL
B1	NULL
(	NULL
p50/p105	NULL
)	NULL
mRNA	NULL
Steady-State	NULL
Level	NULL
Is	NULL
Increased	NULL
upon	NULL
CD2+CD28	NULL
Costimulation	NULL
.	NULL

Northern	NULL
blot	NULL
analyses	NULL
were	NULL
performed	NULL
to	NULL
follow	NULL
the	NULL
steady-state	NULL
level	NULL
variation	NULL
of	NULL
the	NULL
mRNA	NULL
encoding	NULL
NF-	NULL
«	NULL
B	NULL
p50/p105	NULL
during	NULL
T-cell	NULL
activation	NULL
by	NULL
anti-CD2	NULL
,	NULL
-CD28	NULL
,	NULL
and	NULL
-CD2+€CD28	NULL
.	NULL

A	NULL
low	NULL
steady-state	NULL
level	NULL
of	NULL
the	NULL
transcript	NULL
was	NULL
detected	NULL
in	NULL
peripheral	NULL
unstimulated	NULL
T-cells	NULL
,	NULL
as	NULL
illustrated	NULL
for	NULL
mRNA	NULL
samples	NULL
at	NULL
6	NULL
h	NULL
in	NULL
Fig	NULL
.	NULL

1A	NULL
.	NULL

This	NULL
low	NULL
constitutive	NULL
expression	NULL
was	NULL
not	NULL
strongly	NULL
affected	NULL
by	NULL
either	NULL
the	NULL
CD2	NULL
or	NULL
CD28	NULL
stimulation	NULL
alone	NULL
,	NULL
through	NULL
a	NULL
96-h	NULL
activation	NULL
period	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
B	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
T-cell	NULL
stimulation	NULL
by	NULL
CD2+CD28	NULL
resulted	NULL
in	NULL
a	NULL
rapid	NULL
and	NULL
transient	NULL
rise	NULL
in	NULL
the	NULL
level	NULL
of	NULL
the	NULL
4-kb	NULL
NF-	NULL
«	NULL
B1	NULL
mRNA	NULL
that	NULL
peaked	NULL
at	NULL
6	NULL
h	NULL
and	NULL
was	NULL
at	NULL
least	NULL
a	NULL
6-fold	NULL
increase	NULL
.	NULL

It	NULL
returned	NULL
slowly	NULL
to	NULL
the	NULL
baseline	NULL
level	NULL
within	NULL
72	NULL
h	NULL
after	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
this	NULL
increase	NULL
is	NULL
not	NULL
specific	NULL
for	NULL
CD2+CD28	NULL
costimu-lation	NULL
,	NULL
since	NULL
we	NULL
observed	NULL
a	NULL
comparable	NULL
increase	NULL
when	NULL
using	NULL
coated	NULL
anti-CD3	NULL
mAb	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
the	NULL
same	NULL
RNA	NULL
samples	NULL
,	NULL
a	NULL
2.6-kb	NULL
mRNA	NULL
encoding	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
was	NULL
detected	NULL
that	NULL
was	NULL
not	NULL
enhanced	NULL
upon	NULL
T-cell	NULL
activation	NULL
regardless	NULL
of	NULL
the	NULL
stimulus	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
p50	NULL
and	NULL
p105	NULL
Protein	NULL
Increase	NULL
in	NULL
T-Lymphocytes	NULL
Stimulated	NULL
via	NULL
CD2+CD28	NULL
.	NULL

To	NULL
further	NULL
characterize	NULL
NF-	NULL
«	NULL
kBI	NULL
gene	NULL
expression	NULL
during	NULL
T-cell	NULL
stimulation	NULL
,	NULL
p50	NULL
and	NULL
p105	NULL
protein	NULL
levels	NULL
were	NULL
measured	NULL
in	NULL
both	NULL
cytosolic	NULL
and	NULL
nuclear	NULL
extracts	NULL
by	NULL
Western	NULL
blots	NULL
using	NULL
an	NULL
antiserum	NULL
for	NULL
p50	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
was	NULL
detected	NULL
in	NULL
cytosolic	NULL
fractions	NULL
of	NULL
unstimulated	NULL
T-cells	NULL
as	NULL
a	NULL
major	NULL
55-kDa	NULL
protein	NULL
.	NULL

The	NULL
level	NULL
of	NULL
cytosolic	NULL
p50	NULL
protein	NULL
was	NULL
increased	NULL
2-	NULL
to	NULL
4-fold	NULL
after	NULL
costimulation	NULL
with	NULL
anti-CD2	NULL
and	NULL
-CD28	NULL
with	NULL
reference	NULL
to	NULL
the	NULL
unstimulated	NULL
control	NULL
(	NULL
compare	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
Lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
this	NULL
inducible	NULL
level	NULL
was	NULL
detectable	NULL
as	NULL
soon	NULL
as	NULL
30	NULL
min	NULL
after	NULL
stimulation	NULL
and	NULL
remained	NULL
elevated	NULL
up	NULL
to	NULL
96	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
Lanes	NULL
3	NULL
to	NULL
6	NULL
)	NULL
.	NULL

After	NULL
1	NULL
and	NULL
2	NULL
weeks	NULL
,	NULL
p50	NULL
levels	NULL
dropped	NULL
to	NULL
that	NULL
of	NULL
unstimulated	NULL
cells	NULL
.	NULL

The	NULL
level	NULL
of	NULL
a	NULL
105-kDa	NULL
species	NULL
,	NULL
which	NULL
was	NULL
very	NULL
low	NULL
in	NULL
cytosolic	NULL
extracts	NULL
from	NULL
unstimulated	NULL
T-cells	NULL
,	NULL
was	NULL
also	NULL
increased	NULL
upon	NULL
stimulation	NULL
.	NULL

Increased	NULL
expression	NULL
of	NULL
p105	NULL
,	NULL
the	NULL
p50	NULL
precursor	NULL
,	NULL
was	NULL
maintained	NULL
for	NULL
at	NULL
least	NULL
24	NULL
h	NULL
and	NULL
progressively	NULL
decreased	NULL
to	NULL
basal	NULL
levels	NULL
1	NULL
week	NULL
after	NULL
stimulation	NULL
.	NULL

In	NULL
nuclear	NULL
extracts	NULL
,	NULL
an	NULL
increase	NULL
of	NULL
p50	NULL
protein	NULL
was	NULL
also	NULL
observed	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

It	NULL
was	NULL
also	NULL
detectable	NULL
at	NULL
30	NULL
min	NULL
and	NULL
4.0	NULL
kb	NULL
=	NULL
-	NULL
p50/p105	NULL
1.0	NULL
kb	NULL
=	NULL
..	NULL
“	NULL
-	NULL
Hug2m	NULL
1	NULL
&	NULL
®	NULL
~	NULL
+	NULL
.	NULL

R	NULL
a	NULL
NON	NULL
o	NULL
Activation	NULL
a	NULL
u	NULL
43	NULL
3	NULL
2.0	NULL
4	NULL
#	NULL
CD2+CD28	NULL
2	NULL
a	NULL
CD2	NULL
Pw	NULL
be	NULL
a	NULL
8015	NULL
{	NULL
.D	NULL
k	NULL
S	NULL
lest	NULL
i	NULL
|	NULL
g	NULL
1.0	NULL
\	NULL
.	NULL

2	NULL
~a	NULL
<	NULL
&	NULL
os	NULL
\/l	NULL
6	NULL
>	NULL
E/D\—_u	NULL
’	NULL
/D\	NULL
;	NULL
/D	NULL
o	NULL
O	NULL
o	NULL
A	NULL
.	NULL

0.0	NULL
T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
0	NULL
20	NULL
40	NULL
so	NULL
ao	NULL
100	NULL
Time	NULL
(	NULL
hours	NULL
)	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

-	NULL
Induction	NULL
of	NULL
NF-	NULL
«	NULL
B1	NULL
(	NULL
p50/p105	NULL
)	NULL
mRNA	NULL
by	NULL
CD2	NULL
+CD28	NULL
T-cell	NULL
stimulation	NULL
.	NULL

A	NULL
,	NULL
Northern	NULL
blot	NULL
analysis	NULL
of	NULL
NF-	NULL
«	NULL
B1	NULL
mRNA	NULL
expression	NULL
.	NULL

Purified	NULL
T-lymphocytes	NULL
were	NULL
activated	NULL
with	NULL
CD2	NULL
,	NULL
CD28	NULL
,	NULL
and	NULL
CD2	NULL
+CD28	NULL
mAbs	NULL
,	NULL
as	NULL
described	NULL
in	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
,	NULL
``	NULL
and	NULL
harvested	NULL
at	NULL
6	NULL
h.	NULL
Blots	NULL
containing	NULL
20	NULL
pg/lane	NULL
were	NULL
hybridized	NULL
simultaneously	NULL
with	NULL
NF-	NULL
«	NULL
B1	NULL
and	NULL
HuBam	NULL
cDNA	NULL
probes	NULL
.	NULL

HuBzam	NULL
probe	NULL
was	NULL
used	NULL
to	NULL
control	NULL
RNA	NULL
loading	NULL
and	NULL
to	NULL
quantify	NULL
NF-	NULL
«	NULL
B1	NULL
hybridization	NULL
signal	NULL
.	NULL

8	NULL
,	NULL
mRNA	NULL
time	NULL
course	NULL
in	NULL
CD2-	NULL
or	NULL
CD2+CD28-activated	NULL
T-lymphocytes	NULL
.	NULL

T-cells	NULL
were	NULL
activated	NULL
with	NULL
the	NULL
different	NULL
mAbs	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
,	NULL
and	NULL
the	NULL
4-kb	NULL
NF-	NULL
«	NULL
B1	NULL
(	NULL
p50/p105	NULL
)	NULL
mRNA	NULL
level	NULL
was	NULL
analyzed	NULL
and	NULL
quantified	NULL
as	NULL
described	NULL
in	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

Data	NULL
represent	NULL
the	NULL
mean	NULL
values	NULL
of	NULL
at	NULL
least	NULL
two	NULL
experiments	NULL
with	NULL
different	NULL
donors	NULL
.	NULL

Values	NULL
determined	NULL
for	NULL
CD28-activated	NULL
T-cells	NULL
were	NULL
consistently	NULL
similar	NULL
to	NULL
those	NULL
obtained	NULL
for	NULL
CD2-activated	NULL
cells	NULL
and	NULL
are	NULL
not	NULL
shown	NULL
.	NULL

peaked	NULL
24	NULL
h	NULL
after	NULL
CD2+CD28	NULL
stimulation	NULL
.	NULL

Consistent	NULL
with	NULL
previous	NULL
findings	NULL
,	NULL
no	NULL
p105	NULL
was	NULL
detected	NULL
in	NULL
nuclear	NULL
extracts	NULL
(	NULL
45	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
levels	NULL
of	NULL
nuclear	NULL
p50	NULL
returned	NULL
more	NULL
rapidly	NULL
than	NULL
cytoplasmic	NULL
p50	NULL
to	NULL
basal	NULL
levels	NULL
.	NULL

Surprisingly	NULL
enough	NULL
,	NULL
p50	NULL
levels	NULL
at	NULL
96	NULL
h	NULL
and	NULL
after	NULL
were	NULL
reproducibly	NULL
observed	NULL
below	NULL
those	NULL
of	NULL
unstimulated	NULL
controls	NULL
,	NULL
as	NULL
emphasized	NULL
in	NULL
the	NULL
representative	NULL
experiment	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2B	NULL
.	NULL

The	NULL
delayed	NULL
decrease	NULL
of	NULL
nuclear	NULL
p50	NULL
contrasted	NULL
with	NULL
our	NULL
previous	NULL
observation	NULL
of	NULL
stable	NULL
NF-kB	NULL
and	NULL
KBF1	NULL
complexes	NULL
in	NULL
CD2+CD28-stimulated	NULL
T-cells	NULL
as	NULL
detected	NULL
by	NULL
EMSA	NULL
(	NULL
43	NULL
)	NULL
and	NULL
UV-crosslinking	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

As	NULL
illustrated	NULL
by	NULL
comparison	NULL
of	NULL
panels	NULL
A	NULL
and	NULL
B	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
T-cell	NULL
cytoplasm	NULL
contained	NULL
apparently	NULL
more	NULL
p50	NULL
protein	NULL
than	NULL
nucleus	NULL
,	NULL
since	NULL
8	NULL
pg	NULL
of	NULL
nuclear	NULL
fraction	NULL
are	NULL
usually	NULL
required	NULL
to	NULL
provide	NULL
a	NULL
comparable	NULL
signal	NULL
to	NULL
2	NULL
pg	NULL
of	NULL
cytosol	NULL
when	NULL
detected	NULL
by	NULL
ECL-Western	NULL
blotting	NULL
.	NULL

By	NULL
loading	NULL
equal	NULL
amounts	NULL
of	NULL
both	NULL
fractions	NULL
and	NULL
surface	NULL
area	NULL
quantification	NULL
,	NULL
we	NULL
confirmed	NULL
that	NULL
cytosol	NULL
contained	NULL
apparently	NULL
5	NULL
times	NULL
more	NULL
p50	NULL
protein	NULL
than	NULL
did	NULL
the	NULL
nuclear	NULL
fraction	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

-	NULL
Cytoplasmic	NULL
and	NULL
nuclear	NULL
detection	NULL
of	NULL
p50	NULL
and	NULL
p105	NULL
proteins	NULL
by	NULL
Western	NULL
blotting	NULL
during	NULL
long-term	NULL
CD2	NULL
+€D28	NULL
costimulation	NULL
.	NULL

Cytosolic	NULL
and	NULL
nuclear	NULL
extracts	NULL
from	NULL
unstimulated	NULL
or	NULL
CD2+CD28-stimulated	NULL
T-cells	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
polyacrylamide	NULL
gel	NULL
under	NULL
denaturing	NULL
conditions	NULL
,	NULL
transferred	NULL
on	NULL
to	NULL
an	NULL
Immobilon-P	NULL
membrane	NULL
,	NULL
and	NULL
incubated	NULL
with	NULL
an	NULL
anti-p5ON	NULL
serum	NULL
.	NULL

Fixation	NULL
of	NULL
specific	NULL
antibodies	NULL
was	NULL
detected	NULL
using	NULL
a	NULL
commercial	NULL
chemilu-minescent	NULL
kit	NULL
(	NULL
ECL	NULL
;	NULL
Amersham	NULL
}	NULL
,	NULL
as	NULL
described	NULL
in	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

A	NULL
,	NULL
cytosolic	NULL
extracts	NULL
(	NULL
2	NULL
pg/	NULL
lane	NULL
}	NULL
;	NULL
B	NULL
,	NULL
nuclear	NULL
extracts	NULL
(	NULL
8	NULL
pg/lane	NULL
)	NULL
.	NULL

Under	NULL
our	NULL
electrophoresis	NULL
conditions	NULL
,	NULL
endogenous	NULL
T-lymphocyte	NULL
p50	NULL
migrated	NULL
as	NULL
a	NULL
55-kDa	NULL
polypeptide	NULL
when	NULL
detected	NULL
by	NULL
Western	NULL
blotting	NULL
.	NULL

As	NULL
control	NULL
,	NULL
recombinant	NULL
p50	NULL
corresponding	NULL
to	NULL
an	NULL
arbitrarily	NULL
truncated	NULL
form	NULL
of	NULL
p105	NULL
(	NULL
amino	NULL
acids	NULL
1	NULL
to	NULL
399	NULL
)	NULL
(	NULL
22	NULL
)	NULL
migrated	NULL
significantly	NULL
faster	NULL
than	NULL
endogenous	NULL
p50	NULL
(	NULL
A	NULL
,	NULL
Lane	NULL
1	NULL
)	NULL
.	NULL

Numbers	NULL
at	NULL
right	NULL
,	NULL
molecular	NULL
weight	NULL
of	NULL
revealed	NULL
poly-peptides	NULL
.	NULL

Filled	NULL
arrowhead	NULL
,	NULL
the	NULL
main	NULL
55-kDa	NULL
polypeptide	NULL
(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
;	NULL
open	NULL
arrowhead	NULL
,	NULL
the	NULL
105-kDa	NULL
polypeptide	NULL
(	NULL
A	NULL
)	NULL
.	NULL

50	NULL
kd	NULL
CD2+CD28	NULL
stimulation	NULL
induced	NULL
a	NULL
rapid	NULL
cytoplasmic	NULL
increase	NULL
in	NULL
p50	NULL
and	NULL
p105	NULL
proteins	NULL
and	NULL
an	NULL
increase	NULL
in	NULL
nuclear	NULL
p50	NULL
.	NULL

CD2+CD28	NULL
Stimulation	NULL
Increases	NULL
the	NULL
Cytoplasmic	NULL
Level	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
DNA-binding	NULL
Complexes	NULL
.	NULL

Since	NULL
we	NULL
previously	NULL
observed	NULL
a	NULL
stable	NULL
level	NULL
of	NULL
«	NULL
B-specific	NULL
DNA-binding	NULL
activity	NULL
in	NULL
nuclear	NULL
extracts	NULL
of	NULL
CD2+CD28-activated	NULL
T-cells	NULL
(	NULL
43	NULL
)	NULL
and	NULL
an	NULL
apparent	NULL
excess	NULL
of	NULL
immunodetected	NULL
cytoplasmic	NULL
p50	NULL
,	NULL
we	NULL
tried	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
cytosolic	NULL
p50	NULL
protein	NULL
was	NULL
an	NULL
active	NULL
DNA-binding	NULL
form	NULL
.	NULL

EMSA	NULL
assays	NULL
were	NULL
performed	NULL
to	NULL
quantify	NULL
«	NULL
B-specific	NULL
DNA-binding	NULL
activities	NULL
in	NULL
cytosolic	NULL
fractions	NULL
prepared	NULL
from	NULL
purified	NULL
T-cells	NULL
before	NULL
and	NULL
after	NULL
CD2	NULL
and	NULL
CD28	NULL
costimulation	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
we	NULL
detected	NULL
two	NULL
major	NULL
cytoplasmic	NULL
DNA-binding	NULL
complexes	NULL
using	NULL
a	NULL
5	NULL
end-labeled	NULL
B	NULL
,	NULL
,	NULL
.	NULL

>	NULL
;	NULL
;	NULL
,	NULL
,	NULL
oligonucleotide	NULL
probe	NULL
.	NULL

The	NULL
faster	NULL
migrating	NULL
complex	NULL
was	NULL
nonspecific	NULL
,	NULL
since	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
under	NULL
our	NULL
experimental	NULL
conditions	NULL
(	NULL
43	NULL
)	NULL
,	NULL
it	NULL
was	NULL
equally	NULL
competed	NULL
by	NULL
specific	NULL
and	NULL
nonspecific	NULL
competitors	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
upper	NULL
band	NULL
was	NULL
constitutively	NULL
detected	NULL
in	NULL
cytosol	NULL
,	NULL
and	NULL
its	NULL
amount	NULL
weakly	NULL
increased	NULL
upon	NULL
CD2+CD28	NULL
costimulation	NULL
.	NULL

Antiserum	NULL
(	NULL
no	NULL
.	NULL

3	NULL
)	NULL
,	NULL
which	NULL
specifically	NULL
recognizes	NULL
KBF1/p50	NULL
homodimers	NULL
,	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
upper	NULL
band	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
antiserum	NULL
no	NULL
.	NULL

2	NULL
,	NULL
which	NULL
is	NULL
directed	NULL
against	NULL
both	NULL
p50	NULL
homodimer	NULL
and	NULL
p50/p65	NULL
heterodimer	NULL
,	NULL
almost	NULL
completely	NULL
abolished	NULL
the	NULL
band	NULL
.	NULL

Recombinant	NULL
MAD-3/t	NULL
«	NULL
kBa	NULL
,	NULL
which	NULL
abrogates	NULL
in	NULL
vitro	NULL
DNA	NULL
binding	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p50/p65	NULL
heterodimer	NULL
to	NULL
the	NULL
«	NULL
B	NULL
site	NULL
(	NULL
46	NULL
)	NULL
,	NULL
fully	NULL
sup	NULL
CcYTOoSsoL	NULL
CD2	NULL
+	NULL
CD28	NULL
Nucleus	NULL
&	NULL
325	NULL
CD2+CD28	NULL
&	NULL
C	NULL
a	NULL
§	NULL
§	NULL
&	NULL
€	NULL
$	NULL
$	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
pressed	NULL
formation	NULL
of	NULL
the	NULL
upper	NULL
complex	NULL
.	NULL

Consequently	NULL
,	NULL
the	NULL
inducible	NULL
«	NULL
B-specific	NULL
DNA-binding	NULL
activity	NULL
present	NULL
in	NULL
cytosol	NULL
of	NULL
unstimulated	NULL
and	NULL
CD2+CD28-stimulated	NULL
T-cells	NULL
was	NULL
most	NULL
likely	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p50/p65	NULL
heterodimer	NULL
.	NULL

In	NULL
accordance	NULL
with	NULL
previous	NULL
studies	NULL
,	NULL
we	NULL
failed	NULL
to	NULL
detect	NULL
any	NULL
KBF1/	NULL
p50	NULL
homodimers	NULL
in	NULL
T-lymphocyte	NULL
cytosolic	NULL
extracts	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
we	NULL
have	NULL
previously	NULL
reported	NULL
(	NULL
43	NULL
)	NULL
that	NULL
resting	NULL
and	NULL
stimulated	NULL
T-cell	NULL
nuclear	NULL
extracts	NULL
both	NULL
contained	NULL
relatively	NULL
high	NULL
but	NULL
stable	NULL
levels	NULL
of	NULL
KBF1/p50	NULL
homodimers	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
data	NULL
show	NULL
that	NULL
increased	NULL
expression	NULL
of	NULL
NF-	NULL
«	NULL
BI	NULL
gene	NULL
does	NULL
not	NULL
lead	NULL
to	NULL
a	NULL
parallel	NULL
formation	NULL
of	NULL
more	NULL
active	NULL
KBF1/	NULL
p50	NULL
homodimers	NULL
in	NULL
either	NULL
cytosolic	NULL
or	NULL
nuclear	NULL
extracts	NULL
.	NULL

NF-	NULL
«	NULL
B1	NULL
Gene	NULL
Antisense	NULL
Oligodeoxynucleotide	NULL
Inhibits	NULL
p50	NULL
and	NULL
p105	NULL
Protein	NULL
Increase	NULL
and	NULL
T-Cell	NULL
Proliferation	NULL
.	NULL

To	NULL
assess	NULL
the	NULL
role	NULL
of	NULL
NF-	NULL
«	NULL
kB1	NULL
gene	NULL
in	NULL
CD2+CD28	NULL
stimulation	NULL
,	NULL
purified	NULL
human	NULL
T-cells	NULL
were	NULL
treated	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
sense	NULL
and	NULL
antisense	NULL
oligonucleotides	NULL
before	NULL
and	NULL
after	NULL
CD2+CD28	NULL
stimulation	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
NF-	NULL
«	NULL
B1	NULL
antisense	NULL
oligonucleotide	NULL
(	NULL
22.5	NULL
um	NULL
concentration	NULL
)	NULL
reduced	NULL
the	NULL
amount	NULL
of	NULL
p50	NULL
polypeptide	NULL
detected	NULL
24	NULL
h	NULL
poststimulation	NULL
by	NULL
36	NULL
%	NULL
relative	NULL
to	NULL
cells	NULL
stimulated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
NF-	NULL
«	NULL
BI1	NULL
sense	NULL
oligonucleotide	NULL
.	NULL

Similarly	NULL
,	NULL
p105	NULL
protein	NULL
level	NULL
was	NULL
reduced	NULL
by	NULL
63	NULL
%	NULL
.	NULL

RelA	NULL
(	NULL
p65	NULL
)	NULL
sense	NULL
and	NULL
antisense	NULL
oligonucleotides	NULL
did	NULL
not	NULL
affect	NULL
p50	NULL
and	NULL
p105	NULL
protein	NULL
levels	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Since	NULL
NF-	NULL
«	NULL
B1	NULL
antisense	NULL
oligonucleotides	NULL
inhibited	NULL
p50	NULL
and	NULL
p105	NULL
protein	NULL
synthesis	NULL
,	NULL
their	NULL
effect	NULL
on	NULL
CD2+CD28	NULL
949	NULL
950	NULL
Role	NULL
of	NULL
NF-	NULL
«	NULL
B1	NULL
Gene	NULL
in	NULL
CD2+CD28	NULL
Activation	NULL
CD2	NULL
+CD28	NULL
unstimulated	NULL
3h	NULL
1iwk	NULL
[	NULL
7	NULL
/	NULL
~-7	NULL
,	NULL
~-4	NULL
C	NULL
*	NULL
&	NULL
1	NULL
7	NULL
1	NULL
Psa	NULL
-	NULL
$	NULL
¢	NULL
$	NULL
2	NULL
&	NULL
_	NULL
$	NULL
P	NULL
&	NULL
_	NULL
$	NULL
2	NULL
&	NULL
_	NULL
we	NULL
<	NULL
4	NULL
NF-kB	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
°	NULL
6	NULL
7	NULL
8	NULL
9	NULL
G	NULL
11	NULL
12	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Cytosolic	NULL
«	NULL
B-specific	NULL
DNA-binding	NULL
activity	NULL
during	NULL
CD2+CD28	NULL
stimulation	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
cytosolic	NULL
extracts	NULL
(	NULL
1	NULL
ug	NULL
)	NULL
from	NULL
unstimulated	NULL
(	NULL
Lanes	NULL
1-4	NULL
)	NULL
or	NULL
CD2	NULL
+CD28-stimulated	NULL
T-lymphocytes	NULL
(	NULL
Lanes	NULL
5-8	NULL
,	NULL
3	NULL
h	NULL
;	NULL
Lanes	NULL
9-12	NULL
,	NULL
1	NULL
week	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
xByg	NULL
,	NULL
,	NULL
oligonucleotide	NULL
probe	NULL
and	NULL
analyzed	NULL
on	NULL
a	NULL
polyacrylamide	NULL
gel	NULL
under	NULL
nondenaturing	NULL
conditions	NULL
.	NULL

Reaction	NULL
mixtures	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
the	NULL
presence	NULL
of	NULL
specific	NULL
antisera	NULL
no	NULL
.	NULL

2	NULL
and	NULL
no	NULL
.	NULL

3	NULL
,	NULL
or	NULL
recombinant	NULL
MAD-3/l	NULL
«	NULL
B	NULL
«	NULL
,	NULL
as	NULL
indicated	NULL
at	NULL
top	NULL
of	NULL
lanes	NULL
.	NULL

Filled	NULL
arrowhead	NULL
,	NULL
the	NULL
«	NULL
B-specific	NULL
complex	NULL
;	NULL
open	NULL
arrowhead	NULL
,	NULL
a	NULL
nonspecific	NULL
band	NULL
.	NULL

induced	NULL
T-lymphocyte	NULL
proliferation	NULL
was	NULL
tested	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
increasing	NULL
amounts	NULL
of	NULL
human	NULL
Re/lA	NULL
(	NULL
p65	NULL
)	NULL
sense	NULL
and	NULL
antisense	NULL
oligonucleotides	NULL
inhibited	NULL
cell	NULL
proliferation	NULL
similarly	NULL
(	NULL
41	NULL
%	NULL
and	NULL
45	NULL
%	NULL
,	NULL
respectively	NULL
,	NULL
at	NULL
22.5	NULL
um	NULL
concentration	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
NF-	NULL
«	NULL
B1	NULL
antisense	NULL
oligonucleotide	NULL
reduced	NULL
T-cell	NULL
proliferation	NULL
(	NULL
89	NULL
%	NULL
)	NULL
more	NULL
efficiently	NULL
than	NULL
NF-	NULL
«	NULL
BI1	NULL
sense	NULL
(	NULL
63	NULL
%	NULL
)	NULL
and	NULL
both	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
sense	NULL
and	NULL
antisense	NULL
oligonucleotides	NULL
(	NULL
P	NULL
<	NULL
0.01	NULL
at	NULL
22.5	NULL
pm	NULL
,	NULL
paired	NULL
ftest	NULL
)	NULL
.	NULL

After	NULL
NF-	NULL
«	NULL
BI1	NULL
antisense	NULL
oligomer	NULL
treatment	NULL
at	NULL
22.5	NULL
pm	NULL
,	NULL
T-cell	NULL
proliferation	NULL
was	NULL
reduced	NULL
by	NULL
70	NULL
%	NULL
relative	NULL
to	NULL
NF-	NULL
«	NULL
B1	NULL
sense	NULL
control	NULL
.	NULL

The	NULL
same	NULL
effects	NULL
were	NULL
observed	NULL
in	NULL
six	NULL
independent	NULL
experiments	NULL
performed	NULL
in	NULL
duplicate	NULL
using	NULL
two	NULL
different	NULL
oligonucleotide	NULL
preparations	NULL
.	NULL

The	NULL
absence	NULL
of	NULL
cell	NULL
toxicity	NULL
was	NULL
controlled	NULL
by	NULL
trypan	NULL
blue	NULL
exclusion	NULL
and	NULL
microscopic	NULL
observation	NULL
(	NULL
cell	NULL
viability	NULL
greater	NULL
than	NULL
90	NULL
%	NULL
under	NULL
all	NULL
conditions	NULL
)	NULL
.	NULL

We	NULL
next	NULL
studied	NULL
the	NULL
oligonucleotide	NULL
effect	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
proliferation-associated	NULL
gene	NULL
/L-2Ra	NULL
,	NULL
which	NULL
is	NULL
highly	NULL
induced	NULL
upon	NULL
CD2	NULL
+CD28	NULL
stimulation	NULL
(	NULL
9	NULL
)	NULL
and	NULL
whose	NULL
promoter	NULL
contains	NULL
a	NULL
well-characterized	NULL
NF-kB	NULL
DNA-binding	NULL
site	NULL
(	NULL
47	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
CD25/IL-2Ra	NULL
was	NULL
examined	NULL
at	NULL
72	NULL
h	NULL
after	NULL
addition	NULL
of	NULL
anti-CD2	NULL
and	NULL
anti-CD28	NULL
mAbs	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Exposure	NULL
to	NULL
NF-	NULL
«	NULL
B1	NULL
antisense	NULL
oligodeoxynucleotides	NULL
reduced	NULL
CD25/IL-2Ra	NULL
expression	NULL
by	NULL
41	NULL
%	NULL
(	NULL
27.5	NULL
%	NULL
versus	NULL
46	NULL
%	NULL
positive	NULL
cells	NULL
)	NULL
when	NULL
compared	NULL
to	NULL
cells	NULL
treated	NULL
with	NULL
NF-	NULL
«	NULL
B1	NULL
sense	NULL
oligodeoxynucleotides	NULL
at	NULL
the	NULL
same	NULL
concentration	NULL
(	NULL
22.5	NULL
pim	NULL
)	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
T-cell	NULL
treatment	NULL
with	NULL
NF-	NULL
«	NULL
B1	NULL
antisense	NULL
unmodified	NULL
oligodeoxynucleotides	NULL
inhibited	NULL
p50	NULL
and	NULL
p105	NULL
protein	NULL
overexpression	NULL
and	NULL
significantly	NULL
reduced	NULL
T-cell	NULL
proliferation	NULL
and	NULL
CD25/IL-2Ra	NULL
expression	NULL
triggered	NULL
by	NULL
CD2+CD28	NULL
costimulation	NULL
.	NULL

Discussion	NULL
Recent	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
a	NULL
major	NULL
transcription	NULL
factor	NULL
involved	NULL
in	NULL
cellular	NULL
response	NULL
to	NULL
a	NULL
large	NULL
variety	NULL
of	NULL
stimuli	NULL
(	NULL
16	NULL
)	NULL
.	NULL

The	NULL
role	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
T-lymphocytes	NULL
was	NULL
mainly	NULL
studied	NULL
in	NULL
tumor	NULL
models	NULL
such	NULL
as	NULL
Jurkat	NULL
,	NULL
an	NULL
acute	NULL
lympho-cytic	NULL
leukemia	NULL
T-cell	NULL
line	NULL
(	NULL
for	NULL
a	NULL
review	NULL
,	NULL
see	NULL
Ref	NULL
.	NULL

37	NULL
)	NULL
.	NULL

To	NULL
assess	NULL
the	NULL
physiological	NULL
relevance	NULL
of	NULL
these	NULL
observations	NULL
in	NULL
pri-	NULL
6	NULL
t+	NULL
«	NULL
<	NULL
4	NULL
105kd	NULL
<	NULL
4	NULL
55	NULL
kd	NULL
100	NULL
B0	NULL
60	NULL
40	NULL
Proliferation	NULL
(	NULL
%	NULL
)	NULL
O	NULL
p65	NULL
sense	NULL
®	NULL
p65	NULL
antisense	NULL
20	NULL
{	NULL
|O	NULL
p§50	NULL
sense	NULL
s	NULL
p50	NULL
antisense	NULL
O	NULL
I	NULL
U	NULL
T	NULL
T	NULL
0.0	NULL
7.5	NULL
15.0	NULL
22.5	NULL
Oligonucleotide	NULL
(	NULL
uM	NULL
)	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

-	NULL
Antisense	NULL
oligonucleotide	NULL
effects	NULL
on	NULL
NF-kB	NULL
!	NULL

gene	NULL
expression	NULL
and	NULL
T-cell	NULL
proliferation	NULL
.	NULL

A	NULL
,	NULL
equal	NULL
amounts	NULL
of	NULL
whole	NULL
protein	NULL
extracts	NULL
of	NULL
CD2+CD28-stimulated	NULL
T-cells	NULL
(	NULL
24	NULL
h	NULL
,	NULL
5	NULL
x	NULL
10°	NULL
cells/lane	NULL
)	NULL
treated	NULL
with	NULL
human	NULL
NF-	NULL
«	NULL
B1	NULL
p50	NULL
sense	NULL
(	NULL
S	NULL
,	NULL
Lane	NULL
1	NULL
)	NULL
or	NULL
antisense	NULL
(	NULL
AS	NULL
,	NULL
Lane	NULL
2	NULL
)	NULL
oligomers	NULL
were	NULL
revealed	NULL
by	NULL
immunoblotting	NULL
with	NULL
anti-p50	NULL
antiserum	NULL
.	NULL

Arrowheads	NULL
,	NULL
the	NULL
two	NULL
main	NULL
polypeptides	NULL
detected	NULL
:	NULL
p50	NULL
(	NULL
filled	NULL
arrowhead	NULL
)	NULL
and	NULL
its	NULL
precursor	NULL
p105	NULL
(	NULL
open	NULL
arrowhead	NULL
)	NULL
.	NULL

B	NULL
,	NULL
inhibition	NULL
of	NULL
T-lymphocyte	NULL
proliferation	NULL
by	NULL
antisense	NULL
oligonucleotides	NULL
.	NULL

Human	NULL
Re/A	NULL
(	NULL
p65	NULL
)	NULL
sense	NULL
(	NULL
0	NULL
)	NULL
and	NULL
antisense	NULL
(	NULL
@	NULL
)	NULL
oligonucteo-tides	NULL
;	NULL
human	NULL
NF-	NULL
«	NULL
B1	NULL
p50	NULL
sense	NULL
(	NULL
0	NULL
)	NULL
and	NULL
antisense	NULL
oligonucleotides	NULL
.	NULL

Purified	NULL
T-cells	NULL
were	NULL
preincubated	NULL
for	NULL
3	NULL
h	NULL
with	NULL
increasing	NULL
concentrations	NULL
of	NULL
oligonucleotides	NULL
(	NULL
0	NULL
,	NULL
7.5	NULL
,	NULL
15	NULL
,	NULL
and	NULL
22.5	NULL
pm	NULL
)	NULL
and	NULL
then	NULL
stimulated	NULL
by	NULL
CD2+CD28	NULL
.	NULL

After	NULL
96	NULL
h	NULL
,	NULL
proliferation	NULL
was	NULL
measured	NULL
by	NULL
MTT	NULL
assay	NULL
and	NULL
expressed	NULL
as	NULL
a	NULL
percentage	NULL
relative	NULL
to	NULL
stimulated	NULL
control	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
oli-gonucleotide	NULL
,	NULL
corrected	NULL
for	NULL
unstimulated	NULL
background	NULL
.	NULL

Each	NULL
value	NULL
represents	NULL
the	NULL
average	NULL
of	NULL
5	NULL
to	NULL
9	NULL
independent	NULL
duplicate	NULL
determinations	NULL
obtained	NULL
from	NULL
2	NULL
different	NULL
donors	NULL
.	NULL

Bars	NULL
,	NULL
SE	NULL
.	NULL

Cell	NULL
viability	NULL
remained	NULL
greater	NULL
than	NULL
90	NULL
%	NULL
under	NULL
all	NULL
conditions	NULL
(	NULL
as	NULL
determined	NULL
by	NULL
trypan	NULL
blue	NULL
exclusion	NULL
)	NULL
.	NULL

mary	NULL
cells	NULL
,	NULL
we	NULL
are	NULL
currently	NULL
investigating	NULL
the	NULL
role	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
human	NULL
peripheral	NULL
T-lymphocytes	NULL
activated	NULL
via	NULL
CD2	NULL
and	NULL
CD28	NULL
adhesion	NULL
molecules	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
the	NULL
well-defined	NULL
NF-KB	NULL
activation	NULL
mechanism	NULL
in	NULL
T-cells	NULL
,	NULL
we	NULL
previously	NULL
reported	NULL
that	NULL
long-term	NULL
expression	NULL
of	NULL
the	NULL
active	NULL
nuclear	NULL
form	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p50/p65	NULL
heterodimers	NULL
is	NULL
posttranslationally	NULL
induced	NULL
in	NULL
response	NULL
to	NULL
activation	NULL
by	NULL
CD2	NULL
and	NULL
CD28	NULL
adhesion	NULL
molecules	NULL
(	NULL
43	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
demonstrated	NULL
in	NULL
addition	NULL
a	NULL
transient	NULL
increase	NULL
of	NULL
NF-	NULL
«	NULL
BI	NULL
gene	NULL
expression	NULL
at	NULL
both	NULL
mRNA	NULL
and	NULL
protein	NULL
levels	NULL
.	NULL

Although	NULL
gene	NULL
induction	NULL
required	NULL
a	NULL
CD2+CD28	NULL
combination	NULL
,	NULL
this	NULL
increase	NULL
was	NULL
also	NULL
observed	NULL
with	NULL
CD3/TcR	NULL
antigen-dependent	NULL
stimulation	NULL
.	NULL

These	NULL
data	NULL
support	NULL
positive	NULL
transcriptional	NULL
regulation	NULL
of	NULL
NF-	NULL
«	NULL
B1	NULL
gene	NULL
in	NULL
primary	NULL
T-cells	NULL
in	NULL
addition	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
nuclear	NULL
translocation	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
Table	NULL
1	NULL
NF-	NULL
«	NULL
B1	NULL
antisense	NULL
oligodeoxynucleotide	NULL
effects	NULL
on	NULL
surface	NULL
expression	NULL
of	NULL
CD25/IL-2Ra	NULL
Percentage	NULL
and	NULL
mean	NULL
fluorescence	NULL
intensity	NULL
of	NULL
CD2	NULL
+CD28-stimulated	NULL
cell	NULL
expression	NULL
of	NULL
CD25/IL-2Ra	NULL
after	NULL
72	NULL
h	NULL
of	NULL
culture	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
NF-	NULL
«	NULL
B1	NULL
sense	NULL
and	NULL
antisense	NULL
oligodeoxynucleotides	NULL
.	NULL

Data	NULL
are	NULL
from	NULL
two	NULL
representative	NULL
experiments	NULL
performed	NULL
with	NULL
T-cells	NULL
from	NULL
different	NULL
donors	NULL
.	NULL

As	NULL
control	NULL
,	NULL
CD25/	NULL
IL-2Ra	NULL
expression	NULL
was	NULL
assessed	NULL
on	NULL
unstimulated	NULL
cells	NULL
and	NULL
on	NULL
CD2+CD28-stimulated	NULL
cells	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
oligonucleotides	NULL
.	NULL

%	NULL
positive	NULL
cells	NULL
-	NULL
Mean	NULL
fluorescence	NULL
Unstimulated	NULL
2	NULL
,	NULL
4	NULL
23	NULL
,	NULL
136	NULL
CD2+CD28	NULL
69	NULL
,	NULL
79	NULL
212	NULL
,	NULL
193	NULL
CD2+CD28	NULL
+	NULL
p50	NULL
antisense	NULL
29	NULL
,	NULL
26	NULL
71	NULL
,	NULL
92	NULL
CD2+CD28	NULL
+	NULL
p50	NULL
sense	NULL
46	NULL
,	NULL
46	NULL
126	NULL
,	NULL
89	NULL
Cotransfection	NULL
experiments	NULL
have	NULL
recently	NULL
demonstrated	NULL
that	NULL
the	NULL
human	NULL
NF-	NULL
«	NULL
B1	NULL
gene	NULL
promoter	NULL
could	NULL
be	NULL
activated	NULL
by	NULL
either	NULL
p50	NULL
and	NULL
p65	NULL
subunits	NULL
or	NULL
more	NULL
strongly	NULL
by	NULL
the	NULL
combination	NULL
of	NULL
both	NULL
,	NULL
suggesting	NULL
the	NULL
existence	NULL
of	NULL
a	NULL
positive	NULL
autoregulatory	NULL
loop	NULL
for	NULL
NF-	NULL
«	NULL
kB1	NULL
gene	NULL
(	NULL
48	NULL
,	NULL
49	NULL
)	NULL
.	NULL

Our	NULL
data	NULL
are	NULL
agreement	NULL
with	NULL
this	NULL
hypothesis	NULL
,	NULL
but	NULL
further	NULL
experiments	NULL
are	NULL
required	NULL
to	NULL
confirm	NULL
a	NULL
role	NULL
for	NULL
an	NULL
NF-	NULL
«	NULL
B1	NULL
autoregulatory	NULL
loop	NULL
in	NULL
CD2+CD28	NULL
costimulation	NULL
.	NULL

At	NULL
first	NULL
,	NULL
only	NULL
run-off	NULL
assays	NULL
can	NULL
ultimately	NULL
determine	NULL
whether	NULL
the	NULL
increase	NULL
in	NULL
NF-	NULL
«	NULL
BI	NULL
gene	NULL
expression	NULL
in	NULL
primary	NULL
T-lymphocytes	NULL
results	NULL
from	NULL
a	NULL
transient	NULL
transcriptional	NULL
event	NULL
.	NULL

p50	NULL
is	NULL
most	NULL
probably	NULL
a	NULL
proteolytically	NULL
truncated	NULL
form	NULL
of	NULL
a	NULL
105-kDa	NULL
precursor	NULL
molecule	NULL
(	NULL
p105	NULL
)	NULL
(	NULL
21-24	NULL
)	NULL
.	NULL

The	NULL
parallel	NULL
increase	NULL
of	NULL
p50	NULL
and	NULL
p105	NULL
observed	NULL
by	NULL
Western	NULL
blotting	NULL
supports	NULL
an	NULL
enhanced	NULL
proteolysis	NULL
of	NULL
the	NULL
precursor	NULL
p105	NULL
after	NULL
CD2+CD28	NULL
stimulation	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
kB1	NULL
gene	NULL
expression	NULL
is	NULL
only	NULL
associated	NULL
with	NULL
a	NULL
barely	NULL
detectable	NULL
increase	NULL
of	NULL
cytoplasmic	NULL
p50/p65	NULL
DNA-binding	NULL
activity	NULL
.	NULL

p50	NULL
protein	NULL
up-regulation	NULL
is	NULL
not	NULL
associated	NULL
with	NULL
the	NULL
appearance	NULL
of	NULL
KBF1/	NULL
p50	NULL
homodimers	NULL
in	NULL
cytosol	NULL
,	NULL
which	NULL
has	NULL
never	NULL
been	NULL
ob-served	NULL
.	NULL

Finally	NULL
,	NULL
it	NULL
does	NULL
not	NULL
increase	NULL
the	NULL
relatively	NULL
high	NULL
level	NULL
of	NULL
KBF1/p50	NULL
homodimer	NULL
in	NULL
the	NULL
nucleus	NULL
,	NULL
as	NULL
previously	NULL
reported	NULL
(	NULL
43	NULL
)	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
previous	NULL
observations	NULL
in	NULL
different	NULL
cell	NULL
types	NULL
(	NULL
45	NULL
)	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
in	NULL
primary	NULL
T-cells	NULL
the	NULL
p105	NULL
precursor	NULL
is	NULL
apparently	NULL
confined	NULL
to	NULL
the	NULL
cytoplasm	NULL
,	NULL
whereas	NULL
processed	NULL
p50	NULL
molecules	NULL
are	NULL
found	NULL
in	NULL
both	NULL
the	NULL
cytoplasm	NULL
and	NULL
the	NULL
nucleus	NULL
.	NULL

Despite	NULL
its	NULL
overproduction	NULL
,	NULL
p105	NULL
is	NULL
apparently	NULL
not	NULL
primarily	NULL
used	NULL
to	NULL
sequester	NULL
activated	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
since	NULL
bona	NULL
fide	NULL
NF-	NULL
«	NULL
B	NULL
appears	NULL
in	NULL
the	NULL
nucleus	NULL
under	NULL
the	NULL
same	NULL
stimulation	NULL
conditions	NULL
(	NULL
43	NULL
)	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
data	NULL
show	NULL
that	NULL
newly	NULL
produced	NULL
p50	NULL
is	NULL
only	NULL
in	NULL
part	NULL
included	NULL
into	NULL
p65-ikB	NULL
complexes	NULL
.	NULL

Since	NULL
much	NULL
more	NULL
p50	NULL
was	NULL
detected	NULL
in	NULL
cytosol	NULL
than	NULL
in	NULL
nucleus	NULL
,	NULL
the	NULL
remaining	NULL
cytoplasmic	NULL
p50	NULL
could	NULL
be	NULL
sequestered	NULL
either	NULL
by	NULL
IxB	NULL
or	NULL
by	NULL
p105	NULL
,	NULL
both	NULL
of	NULL
which	NULL
control	NULL
p50	NULL
subcellular	NULL
localization	NULL
(	NULL
26	NULL
,	NULL
44	NULL
,	NULL
50	NULL
,	NULL
51	NULL
)	NULL
.	NULL

Cotransfection	NULL
assays	NULL
in	NULL
the	NULL
Jurkat	NULL
T-cell	NULL
line	NULL
have	NULL
demonstrated	NULL
an	NULL
inhibitory	NULL
effect	NULL
of	NULL
KBF1/p50	NULL
homodimers	NULL
on	NULL
the	NULL
IL-2	NULL
promoter	NULL
«	NULL
B	NULL
motif	NULL
that	NULL
correlated	NULL
with	NULL
down-modulation	NULL
of	NULL
constitutive	NULL
KBF1	NULL
after	NULL
T-cell	NULL
stimulation	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Consequently	NULL
,	NULL
an	NULL
excess	NULL
of	NULL
KBF1	NULL
could	NULL
be	NULL
detrimental	NULL
for	NULL
T-cell	NULL
growth	NULL
through	NULL
inhibition	NULL
of	NULL
a	NULL
critical	NULL
gene	NULL
like	NULL
IL-2	NULL
.	NULL

Inci-dentally	NULL
,	NULL
our	NULL
present	NULL
observation	NULL
that	NULL
the	NULL
immunodetected	NULL
nuclear	NULL
p50	NULL
drops	NULL
below	NULL
the	NULL
unstimulated	NULL
control	NULL
and	NULL
the	NULL
apparently	NULL
stable	NULL
maintenance	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
KBF1/p50	NULL
homodimers	NULL
detected	NULL
by	NULL
EMSA	NULL
(	NULL
43	NULL
)	NULL
could	NULL
be	NULL
of	NULL
physiological	NULL
importance	NULL
and	NULL
indicative	NULL
of	NULL
a	NULL
yet-to-be	NULL
identified	NULL
intra-nuclear	NULL
level	NULL
of	NULL
regulation	NULL
.	NULL

We	NULL
propose	NULL
that	NULL
in	NULL
normal	NULL
T-lymphocytes	NULL
only	NULL
a	NULL
fraction	NULL
of	NULL
p50	NULL
translocated	NULL
to	NULL
the	NULL
nucleus	NULL
after	NULL
stimulation	NULL
is	NULL
active	NULL
for	NULL
DNA	NULL
binding	NULL
.	NULL

The	NULL
remaining	NULL
part	NULL
could	NULL
constitute	NULL
a	NULL
modulable	NULL
pool	NULL
of	NULL
nuclear	NULL
p50	NULL
which	NULL
lacks	NULL
DNA-binding	NULL
activity	NULL
.	NULL

Regardless	NULL
of	NULL
the	NULL
exact	NULL
mechanisms	NULL
involved	NULL
,	NULL
the	NULL
maintenance	NULL
of	NULL
p50	NULL
homodimer	NULL
homeostasis	NULL
appears	NULL
to	NULL
be	NULL
of	NULL
major	NULL
importance	NULL
in	NULL
physiological	NULL
T-cell	NULL
activation	NULL
.	NULL

Down-modulation	NULL
of	NULL
newly	NULL
synthesized	NULL
p50	NULL
and	NULL
p105	NULL
is	NULL
associated	NULL
with	NULL
a	NULL
significant	NULL
inhibition	NULL
of	NULL
T-cell	NULL
proliferation	NULL
and	NULL
CD25/IL-2Ra	NULL
:	NULL
cell	NULL
surface	NULL
expression	NULL
.	NULL

Antisense	NULL
inhibition	NULL
of	NULL
p50	NULL
and	NULL
p105	NULL
induction	NULL
further	NULL
confirms	NULL
that	NULL
new	NULL
synthesis	NULL
of	NULL
p50	NULL
from	NULL
processed	NULL
p105	NULL
participates	NULL
in	NULL
a	NULL
T-cell	NULL
regulatory	NULL
response	NULL
triggered	NULL
via	NULL
CD2+CD28	NULL
.	NULL

Several	NULL
possible	NULL
sites	NULL
of	NULL
sequence-specific	NULL
and	NULL
-nonspecific	NULL
action	NULL
for	NULL
oligodeoxynucleotides	NULL
have	NULL
been	NULL
proposed	NULL
to	NULL
explain	NULL
their	NULL
inhibitory	NULL
action	NULL
along	NULL
the	NULL
information	NULL
flow	NULL
from	NULL
DNA	NULL
to	NULL
protein	NULL
in	NULL
eukaryotic	NULL
cells	NULL
(	NULL
for	NULL
a	NULL
review	NULL
,	NULL
see	NULL
Ref	NULL
.	NULL

52	NULL
)	NULL
.	NULL

Using	NULL
unmodified	NULL
oligodeoxynucleotides	NULL
that	NULL
are	NULL
degraded	NULL
after	NULL
a	NULL
few	NULL
hours	NULL
(	NULL
see	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
``	NULL
)	NULL
,	NULL
each	NULL
individual	NULL
level	NULL
of	NULL
action	NULL
can	NULL
gain	NULL
more	NULL
or	NULL
less	NULL
importance	NULL
relative	NULL
to	NULL
the	NULL
regulation	NULL
of	NULL
its	NULL
target	NULL
gene	NULL
expression	NULL
.	NULL

NF-	NULL
«	NULL
B1	NULL
and	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
genes	NULL
are	NULL
differently	NULL
regulated	NULL
in	NULL
primary	NULL
T-cells	NULL
.	NULL

It	NULL
is	NULL
therefore	NULL
not	NULL
surprising	NULL
that	NULL
we	NULL
observed	NULL
a	NULL
difference	NULL
between	NULL
NF-	NULL
«	NULL
B1	NULL
and	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
oligomer	NULL
effects	NULL
,	NULL
and	NULL
several	NULL
explanations	NULL
can	NULL
be	NULL
proposed	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
any	NULL
significant	NULL
difference	NULL
between	NULL
p65	NULL
sense	NULL
and	NULL
antisense	NULL
oligonucleotides	NULL
,	NULL
we	NULL
considered	NULL
their	NULL
action	NULL
to	NULL
be	NULL
a	NULL
nonspecific	NULL
effect	NULL
,	NULL
perhaps	NULL
due	NULL
to	NULL
association	NULL
with	NULL
a	NULL
key	NULL
enzyme	NULL
for	NULL
cell	NULL
proliferation	NULL
(	NULL
52	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
nonspecific	NULL
effect	NULL
observed	NULL
for	NULL
all	NULL
tested	NULL
oligomers	NULL
at	NULL
22.5	NULL
um	NULL
concentration	NULL
,	NULL
the	NULL
antiproliferative	NULL
action	NULL
observed	NULL
with	NULL
NF-	NULL
«	NULL
B1	NULL
oligomer	NULL
could	NULL
be	NULL
mediated	NULL
through	NULL
RNase	NULL
H	NULL
degradation	NULL
of	NULL
sequence-specific	NULL
RNA/DNA	NULL
duplexes	NULL
created	NULL
between	NULL
oligonucleotides	NULL
and	NULL
mature	NULL
mRNAs	NULL
.	NULL

Alternatively	NULL
,	NULL
NF-	NULL
«	NULL
BI1	NULL
sense	NULL
and	NULL
antisense	NULL
oligonucleotides	NULL
may	NULL
also	NULL
act	NULL
by	NULL
hybridization	NULL
to	NULL
the	NULL
locally	NULL
opened	NULL
loop	NULL
created	NULL
by	NULL
RNA	NULL
po-lymerase	NULL
I1	NULL
and	NULL
direct	NULL
transcription	NULL
inhibition	NULL
by	NULL
steric	NULL
hin-drance	NULL
.	NULL

Inhibition	NULL
of	NULL
CD25/IL-2Ra	NULL
cell	NULL
surface	NULL
expression	NULL
further	NULL
confirmed	NULL
the	NULL
role	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
/L-2Ra	NULL
gene	NULL
up-regulation	NULL
(	NULL
53-56	NULL
)	NULL
.	NULL

As	NULL
CD2+CD28-triggered	NULL
T-cell	NULL
proliferation	NULL
is	NULL
highly	NULL
IL-2	NULL
dependent	NULL
(	NULL
10-12	NULL
)	NULL
,	NULL
comparison	NULL
between	NULL
the	NULL
almost	NULL
complete	NULL
antiproliferative	NULL
effect	NULL
and	NULL
partial	NULL
CD25/IL-2Ra	NULL
inhibition	NULL
further	NULL
suggests	NULL
the	NULL
presence	NULL
of	NULL
additive	NULL
nonspecific	NULL
and	NULL
specific	NULL
effects	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
antisense	NULL
approach	NULL
allows	NULL
us	NULL
to	NULL
discriminate	NULL
between	NULL
the	NULL
contributions	NULL
of	NULL
preexisting	NULL
and	NULL
newly	NULL
synthesized	NULL
active	NULL
NF-	NULL
«	NULL
B1	NULL
gene	NULL
products	NULL
in	NULL
our	NULL
T-cell	NULL
model	NULL
.	NULL

Variable	NULL
effects	NULL
have	NULL
been	NULL
observed	NULL
with	NULL
antisense	NULL
NF-	NULL
«	NULL
B1	NULL
and	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
oligonucleotide	NULL
treatment	NULL
which	NULL
depend	NULL
apparently	NULL
on	NULL
the	NULL
cell	NULL
model	NULL
used	NULL
.	NULL

Inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
both	NULL
NF-	NULL
«	NULL
B1	NULL
and	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
antisense	NULL
oligonucleotides	NULL
strongly	NULL
impaired	NULL
the	NULL
growth	NULL
of	NULL
Tax-transformed	NULL
fibroblastic	NULL
tumors	NULL
in	NULL
vivo	NULL
and	NULL
of	NULL
a	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
l-transformed	NULL
human	NULL
B-lymphocyte	NULL
line	NULL
in	NULL
vitro	NULL
(	NULL
57	NULL
)	NULL
.	NULL

Alternatively	NULL
,	NULL
antisense	NULL
p65-treated	NULL
ES	NULL
and	NULL
tumoral	NULL
cell	NULL
lines	NULL
were	NULL
growth	NULL
inhibited	NULL
in	NULL
comparison	NULL
to	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
sense	NULL
or	NULL
both	NULL
NF-	NULL
«	NULL
B1	NULL
sense	NULL
and	NULL
antisense	NULL
oligonucleotides	NULL
(	NULL
58	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
in	NULL
CD2+CD28-activated	NULL
primary	NULL
T-cells	NULL
,	NULL
only	NULL
antisense	NULL
NF-	NULL
«	NULL
B1	NULL
oligonucleotides	NULL
have	NULL
a	NULL
significant	NULL
antiproliferative	NULL
effect	NULL
.	NULL

These	NULL
discrepancies	NULL
further	NULL
emphasize	NULL
the	NULL
need	NULL
to	NULL
validate	NULL
in	NULL
primary	NULL
cells	NULL
the	NULL
observations	NULL
made	NULL
with	NULL
tumor	NULL
cell	NULL
lines	NULL
.	NULL

They	NULL
also	NULL
confirm	NULL
that	NULL
the	NULL
role	NULL
and	NULL
maintenance	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
differ	NULL
depending	NULL
on	NULL
cell	NULL
type	NULL
and	NULL
activation	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
we	NULL
provide	NULL
direct	NULL
evidence	NULL
that	NULL
up-regulation	NULL
of	NULL
NF-	NULL
«	NULL
B1	NULL
gene	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
primary	NULL
T-cell	NULL
activation	NULL
in	NULL
vitro	NULL
,	NULL
suggesting	NULL
a	NULL
role	NULL
for	NULL
this	NULL
induction	NULL
in	NULL
vivo	NULL
as	NULL
well	NULL
.	NULL

Constitutive	NULL
expression	NULL
and	NULL
disruption	NULL
of	NULL
NF-	NULL
«	NULL
kBI	NULL
951	NULL
952	NULL
-	NULL
Role	NULL
of	NULL
NF-kB	NULL
!	NULL

Gene	NULL
in	NULL
CD2+CD28	NULL
Activation	NULL
gene	NULL
in	NULL
transgenic	NULL
mice	NULL
will	NULL
ultimately	NULL
elucidate	NULL
its	NULL
role	NULL
and	NULL
regulation	NULL
in	NULL
peripheral	NULL
blood	NULL
T-cell	NULL
activation	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
T-Cell	NULL
Purification	NULL
and	NULL
Activation	NULL
.	NULL

Peripheral	NULL
blood	NULL
T-cells	NULL
were	NULL
purified	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
59	NULL
)	NULL
.	NULL

Purity	NULL
of	NULL
T-cell	NULL
preparations	NULL
(	NULL
>	NULL
99	NULL
%	NULL
)	NULL
was	NULL
checked	NULL
by	NULL
immunofluorescence	NULL
labeling	NULL
with	NULL
various	NULL
mAbs	NULL
specific	NULL
for	NULL
monocytic	NULL
,	NULL
B	NULL
,	NULL
and	NULL
natural	NULL
killer	NULL
cells	NULL
.	NULL

Contamination	NULL
by	NULL
monocytes	NULL
was	NULL
also	NULL
controlled	NULL
by	NULL
the	NULL
absence	NULL
of	NULL
T-cell	NULL
proliferation	NULL
upon	NULL
optimal	NULL
stimulation	NULL
with	NULL
phytohemagglutinin	NULL
.	NULL

Stimulations	NULL
were	NULL
performed	NULL
with	NULL
the	NULL
following	NULL
mAbs	NULL
,	NULL
used	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
,	NULL
at	NULL
saturating	NULL
concentrations	NULL
.	NULL

Anti-CD2	NULL
mAb	NULL
39C1.5	NULL
(	NULL
rat	NULL
IgG2a	NULL
)	NULL
and	NULL
6F	NULL
10.3	NULL
(	NULL
mouse	NULL
IgG1	NULL
)	NULL
were	NULL
used	NULL
as	NULL
purified	NULL
mAbs	NULL
at	NULL
10	NULL
pg/ml	NULL
each	NULL
(	NULL
60	NULL
)	NULL
.	NULL

Anti-CD28	NULL
248	NULL
ascitic	NULL
fluid	NULL
(	NULL
mouse	NULL
IgM	NULL
)	NULL
,	NULL
obtained	NULL
from	NULL
Dr.	NULL
A.	NULL
Moretta	NULL
(	NULL
Cancer	NULL
Institute	NULL
,	NULL
Genoa	NULL
,	NULL
Italy	NULL
)	NULL
,	NULL
was	NULL
used	NULL
at	NULL
a	NULL
1/400	NULL
dilution	NULL
.	NULL

Northern	NULL
Blot	NULL
Analysis	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
prepared	NULL
from	NULL
cell	NULL
pellets	NULL
by	NULL
lysis	NULL
in	NULL
guanidinium	NULL
isothiocyanate	NULL
and	NULL
purified	NULL
by	NULL
centrifugation	NULL
through	NULL
a	NULL
cushion	NULL
of	NULL
5.7	NULL
m	NULL
CsCl	NULL
(	NULL
61	NULL
)	NULL
.	NULL

Aliquots	NULL
of	NULL
10	NULL
to	NULL
25	NULL
pg	NULL
of	NULL
total	NULL
RNA	NULL
were	NULL
submitted	NULL
to	NULL
electrophoresis	NULL
in	NULL
agarose-formaldehyde	NULL
gels	NULL
and	NULL
transferred	NULL
to	NULL
nylon	NULL
sheets	NULL
(	NULL
Nytran	NULL
;	NULL
Schleicher	NULL
&	NULL
Schuell	NULL
)	NULL
.	NULL

Blots	NULL
were	NULL
pre-hybridized	NULL
and	NULL
hybridized	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
62	NULL
)	NULL
,	NULL
with	NULL
1	NULL
x	NULL
10°	NULL
cpm/ml	NULL
of	NULL
*°P-labeled	NULL
DNA	NULL
probes	NULL
,	NULL
which	NULL
were	NULL
radiolabeled	NULL
by	NULL
random	NULL
priming	NULL
(	NULL
61	NULL
)	NULL
.	NULL

Probes	NULL
used	NULL
for	NULL
Northern	NULL
blot	NULL
hybridizations	NULL
included	NULL
a	NULL
1.3-kb	NULL
cDNA	NULL
corresponding	NULL
to	NULL
amino	NULL
acids	NULL
1	NULL
to	NULL
339	NULL
from	NULL
human	NULL
NF-	NULL
«	NULL
B1	NULL
in	NULL
RcCMV	NULL
vector	NULL
(	NULL
the	NULL
kind	NULL
gift	NULL
of	NULL
Dr.	NULL
Alain	NULL
Israél	NULL
,	NULL
Institut	NULL
Pas-teur	NULL
,	NULL
Paris	NULL
,	NULL
France	NULL
)	NULL
,	NULL
a	NULL
2.6-kb	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
full-length	NULL
cDNA	NULL
in	NULL
RcCMV	NULL
vector	NULL
(	NULL
63	NULL
)	NULL
,	NULL
and	NULL
,	NULL
as	NULL
a	NULL
control	NULL
for	NULL
relative	NULL
amount	NULL
of	NULL
RNA	NULL
loaded	NULL
,	NULL
a	NULL
0.6-kb	NULL
fragment	NULL
of	NULL
HuBym	NULL
cDNA	NULL
in	NULL
plasmid	NULL
pBR322	NULL
(	NULL
64	NULL
)	NULL
.	NULL

After	NULL
hybridization	NULL
,	NULL
filters	NULL
were	NULL
washed	NULL
at	NULL
42°C	NULL
successively	NULL
in	NULL
2x	NULL
SSC-0.1	NULL
%	NULL
SDS	NULL
,	NULL
down	NULL
to	NULL
0.1	NULL
x	NULL
SSC-0.1	NULL
%	NULL
SDS	NULL
.	NULL

They	NULL
were	NULL
autoradiographed	NULL
on	NULL
Kodak	NULL
XAR-5	NULL
films	NULL
(	NULL
Rochester	NULL
,	NULL
NY	NULL
)	NULL
at	NULL
-80°C	NULL
using	NULL
intensifying	NULL
screens	NULL
.	NULL

Semiquantitative	NULL
analyses	NULL
of	NULL
autoradiograms	NULL
were	NULL
performed	NULL
with	NULL
an	NULL
LKB	NULL
Ultroscan	NULL
laser	NULL
densitometer	NULL
,	NULL
by	NULL
using	NULL
adequate	NULL
exposures	NULL
,	NULL
and	NULL
values	NULL
were	NULL
normalized	NULL
to	NULL
the	NULL
signal	NULL
of	NULL
the	NULL
HuB	NULL
,	NULL
m	NULL
probe	NULL
.	NULL

T-Cell	NULL
Protein	NULL
Extracts	NULL
.	NULL

Cytosolic	NULL
and	NULL
nuclear	NULL
protein	NULL
extracts	NULL
were	NULL
prepared	NULL
essentially	NULL
according	NULL
to	NULL
the	NULL
method	NULL
of	NULL
Schreiber	NULL
et	NULL
al	NULL
.	NULL

(	NULL
65	NULL
)	NULL
,	NULL
modified	NULL
by	NULL
Staal	NULL
et	NULL
al	NULL
.	NULL

(	NULL
66	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
washed	NULL
in	NULL
cold	NULL
Tris-buffered	NULL
saline	NULL
,	NULL
then	NULL
resuspended	NULL
in	NULL
0.4	NULL
ml	NULL
of	NULL
buffer	NULL
A	NULL
(	NULL
10	NULL
mm	NULL
Hepes	NULL
,	NULL
pH	NULL
7.8-10	NULL
mm	NULL
KCI-2	NULL
m	NULL
``	NULL
MgCl	NULL
;	NULL
-1	NULL
mm	NULL
dithiothreitol-0.1	NULL
mm	NULL
EDTA	NULL
,	NULL
0.1	NULL
mm	NULL
phenylImethylsulfonyl	NULL
!	NULL

fluoride	NULL
)	NULL
supplemented	NULL
with	NULL
leupeptin	NULL
(	NULL
0.3	NULL
mg/ml	NULL
;	NULL
Sigma	NULL
)	NULL
,	NULL
and	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Then	NULL
25	NULL
pl	NULL
of	NULL
a	NULL
10	NULL
%	NULL
Nonidet	NULL
P-40	NULL
solution	NULL
(	NULL
Sigma	NULL
)	NULL
were	NULL
added	NULL
,	NULL
and	NULL
cells	NULL
were	NULL
mixed	NULL
vigorously	NULL
for	NULL
15	NULL
s	NULL
and	NULL
then	NULL
centrifuged	NULL
(	NULL
13,000	NULL
rom	NULL
,	NULL
15	NULL
s	NULL
)	NULL
.	NULL

Supernatants	NULL
corresponding	NULL
to	NULL
the	NULL
cytosolic	NULL
fraction	NULL
were	NULL
immediately	NULL
complemented	NULL
to	NULL
50	NULL
mm	NULL
Hepes	NULL
,	NULL
50	NULL
mm	NULL
KCl	NULL
,	NULL
300	NULL
mm	NULL
NaCl	NULL
,	NULL
and	NULL
20	NULL
%	NULL
glycerol	NULL
,	NULL
before	NULL
storage	NULL
at	NULL
-80°C	NULL
.	NULL

Pelleted	NULL
nuclei	NULL
were	NULL
resuspended	NULL
in	NULL
50	NULL
pl	NULL
of	NULL
buffer	NULL
C	NULL
(	NULL
50	NULL
mm	NULL
Hepes	NULL
,	NULL
pH	NULL
7.8-50	NULL
mm	NULL
KCI-300	NULL
mm	NULL
NaCl-O0.1	NULL
mm	NULL
EDTA-1	NULL
mm	NULL
dithiothreitol-0.1	NULL
mm	NULL
phenylmethylsulfonyl	NULL
fluoride-10	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
glycerol	NULL
)	NULL
.	NULL

After	NULL
mixing	NULL
for	NULL
20	NULL
min	NULL
,	NULL
the	NULL
nuclei	NULL
were	NULL
centrifuged	NULL
for	NULL
5	NULL
min	NULL
at	NULL
13,000	NULL
rom	NULL
,	NULL
and	NULL
the	NULL
supernatants	NULL
containing	NULL
the	NULL
nuclear	NULL
proteins	NULL
were	NULL
transferred	NULL
to	NULL
another	NULL
tube	NULL
and	NULL
stored	NULL
at	NULL
-80°C	NULL
.	NULL

Protein	NULL
concentration	NULL
was	NULL
measured	NULL
with	NULL
a	NULL
commercial	NULL
kit	NULL
(	NULL
Bio-Rad	NULL
)	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Bradford	NULL
(	NULL
67	NULL
)	NULL
.	NULL

Effects	NULL
of	NULL
antisense	NULL
oligonucleotide	NULL
on	NULL
NF-kB	NULL
p50	NULL
and	NULL
p105	NULL
polypeptide	NULL
expression	NULL
level	NULL
were	NULL
controlled	NULL
using	NULL
whole	NULL
cell	NULL
extract	NULL
directly	NULL
prepared	NULL
by	NULL
suspension	NULL
of	NULL
T-cell	NULL
pellets	NULL
(	NULL
10°	NULL
cells	NULL
)	NULL
in	NULL
50	NULL
pl	NULL
of	NULL
8	NULL
m	NULL
urea-0.5	NULL
m	NULL
NH	NULL
,	NULL
HCO	NULL
;	NULL
and	NULL
immediately	NULL
stored	NULL
at	NULL
-80°C	NULL
.	NULL

SDS-Polyacrylamide	NULL
Gel	NULL
Electrophoresis	NULL
and	NULL
Western	NULL
Blot	NULL
Analysis	NULL
.	NULL

Cytoplasmic	NULL
,	NULL
nuclear	NULL
,	NULL
and	NULL
whole	NULL
cell	NULL
extracts	NULL
were	NULL
boiled	NULL
in	NULL
reducing	NULL
buffer	NULL
for	NULL
3	NULL
min	NULL
before	NULL
loading	NULL
onto	NULL
a	NULL
10	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
.	NULL

An	NULL
equal	NULL
amount	NULL
of	NULL
proteins	NULL
was	NULL
loaded	NULL
per	NULL
well	NULL
,	NULL
as	NULL
indicated	NULL
in	NULL
the	NULL
figure	NULL
legends	NULL
.	NULL

Following	NULL
electrophoresis	NULL
,	NULL
the	NULL
gels	NULL
were	NULL
transferred	NULL
onto	NULL
an	NULL
Immobilon-P	NULL
membrane	NULL
(	NULL
Millipore	NULL
)	NULL
at	NULL
50	NULL
V	NULL
for	NULL
18	NULL
h	NULL
using	NULL
a	NULL
Trans-blot	NULL
apparatus	NULL
(	NULL
Bio-Rad	NULL
)	NULL
.	NULL

Residual	NULL
binding	NULL
sites	NULL
on	NULL
the	NULL
blotting	NULL
membrane	NULL
were	NULL
blocked	NULL
by	NULL
incubation	NULL
for	NULL
2	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
supplemented	NULL
with	NULL
5	NULL
%	NULL
nonfat	NULL
dry	NULL
milk	NULL
.	NULL

After	NULL
incubation	NULL
with	NULL
either	NULL
rabbit	NULL
anti-p50N	NULL
serum	NULL
(	NULL
1/1000	NULL
difution	NULL
)	NULL
or	NULL
preimmune	NULL
serum	NULL
(	NULL
1/1000	NULL
dilution	NULL
)	NULL
,	NULL
filters	NULL
were	NULL
washed	NULL
six	NULL
times	NULL
with	NULL
phosphate-buffered	NULL
saline-0.1	NULL
%	NULL
Tween	NULL
for	NULL
5	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Then	NULL
peroxidase-labeled	NULL
anti-rabbit	NULL
serum	NULL
from	NULL
donkey	NULL
preformed	NULL
complex	NULL
was	NULL
added	NULL
(	NULL
1/1000	NULL
dilu-tion	NULL
)	NULL
and	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
1	NULL
h.	NULL
After	NULL
washing	NULL
as	NULL
described	NULL
above	NULL
,	NULL
filters	NULL
were	NULL
reacted	NULL
1	NULL
min	NULL
with	NULL
che-miluminescent	NULL
substrate	NULL
luminol	NULL
(	NULL
ECL	NULL
kit	NULL
;	NULL
Amersham	NULL
)	NULL
and	NULL
revealed	NULL
by	NULL
brief	NULL
exposure	NULL
(	NULL
15	NULL
to	NULL
60	NULL
s	NULL
)	NULL
using	NULL
autoradiogra-phy	NULL
films	NULL
(	NULL
Kodak	NULL
XAR-5	NULL
)	NULL
.	NULL

In	NULL
all	NULL
cases	NULL
,	NULL
equal	NULL
protein	NULL
load	NULL
was	NULL
controlled	NULL
by	NULL
Ponceau	NULL
red	NULL
counterstaining	NULL
of	NULL
the	NULL
membrane	NULL
and	NULL
transfer	NULL
efficiency	NULL
by	NULL
Coomassie	NULL
blue	NULL
staining	NULL
of	NULL
the	NULL
gel	NULL
after	NULL
electrotransfer	NULL
.	NULL

Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assay	NULL
.	NULL

Oligonucleotides	NULL
were	NULL
labeled	NULL
using	NULL
[	NULL
y-	NULL
>	NULL
2P	NULL
]	NULL
JATP	NULL
and	NULL
polynucleotide	NULL
kinase	NULL
,	NULL
annealed	NULL
,	NULL
and	NULL
gel	NULL
purified	NULL
for	NULL
isolation	NULL
of	NULL
double-stranded	NULL
probes	NULL
.	NULL

Reactions	NULL
with	NULL
equal	NULL
amounts	NULL
of	NULL
nuclear	NULL
extracts	NULL
(	NULL
1	NULL
pg/reaction	NULL
)	NULL
were	NULL
performed	NULL
in	NULL
20	NULL
ul	NULL
final	NULL
volume	NULL
in	NULL
buffer	NULL
C	NULL
containing	NULL
50,000	NULL
cpm	NULL
probe	NULL
,	NULL
0.25	NULL
pug	NULL
poly-deoxyinosinic-deoxycytidylic	NULL
acid	NULL
,	NULL
and	NULL
20	NULL
ug	NULL
bovine	NULL
serum	NULL
albumin	NULL
.	NULL

After	NULL
incubation	NULL
for	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
binding	NULL
reaction	NULL
mixtures	NULL
were	NULL
loaded	NULL
on	NULL
a	NULL
5	NULL
%	NULL
nondenaturing	NULL
polyacrylamide	NULL
gel	NULL
in	NULL
0.25	NULL
%	NULL
TBE	NULL
(	NULL
1	NULL
%	NULL
TBE	NULL
=	NULL
89	NULL
mm	NULL
Tris-89	NULL
mm	NULL
boric	NULL
acid-1	NULL
mm	NULL
EDTA	NULL
)	NULL
.	NULL

After	NULL
electrophoresis	NULL
,	NULL
dried	NULL
gels	NULL
were	NULL
exposed	NULL
at	NULL
-80°C	NULL
to	NULL
Kodak	NULL
XAR-5	NULL
film	NULL
on	NULL
intensifying	NULL
screens	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

For	NULL
competition	NULL
assays	NULL
,	NULL
unlabeled	NULL
complementary	NULL
oligonucleotides	NULL
were	NULL
gel	NULL
purified	NULL
after	NULL
annealing	NULL
.	NULL

Unlabeled	NULL
competitor	NULL
,	NULL
specific	NULL
antise-rum	NULL
,	NULL
or	NULL
recombinant	NULL
protein	NULL
was	NULL
added	NULL
to	NULL
reaction	NULL
mixture	NULL
just	NULL
before	NULL
adding	NULL
the	NULL
radiolabeled	NULL
probe	NULL
.	NULL

Oligodeoxynucleotide	NULL
and	NULL
Proliferation	NULL
Assays	NULL
.	NULL

Cells	NULL
{	NULL
105/well	NULL
)	NULL
were	NULL
seeded	NULL
in	NULL
flat-bottomed	NULL
microtiter	NULL
plates	NULL
in	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
2	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
200	NULL
pul/well	NULL
)	NULL
and	NULL
incubated	NULL
for	NULL
3	NULL
h	NULL
at	NULL
37°C	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
various	NULL
doses	NULL
of	NULL
oligonucleotides	NULL
,	NULL
as	NULL
indicated	NULL
in	NULL
the	NULL
figure	NULL
legends	NULL
.	NULL

Then	NULL
CD2	NULL
and	NULL
CD28	NULL
mAbs	NULL
(	NULL
at	NULL
the	NULL
above	NULL
mentioned	NULL
concentrations	NULL
)	NULL
were	NULL
added	NULL
or	NULL
not	NULL
,	NULL
and	NULL
the	NULL
concentration	NULL
of	NULL
serum	NULL
was	NULL
raised	NULL
to	NULL
10	NULL
%	NULL
.	NULL

After	NULL
96	NULL
h	NULL
culture	NULL
,	NULL
an	NULL
MTT	NULL
assay	NULL
(	NULL
Sigma	NULL
)	NULL
was	NULL
used	NULL
as	NULL
an	NULL
alternative	NULL
to	NULL
radioisotope	NULL
incorporation	NULL
to	NULL
measure	NULL
cell	NULL
growth	NULL
and	NULL
to	NULL
avoid	NULL
any	NULL
nonspecific	NULL
inhibition	NULL
due	NULL
to	NULL
the	NULL
possible	NULL
presence	NULL
of	NULL
free	NULL
thy-midine	NULL
from	NULL
degraded	NULL
oligonucleotides	NULL
.	NULL

Briefly	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
20	NULL
pl	NULL
of	NULL
an	NULL
MTT	NULL
solution	NULL
(	NULL
5	NULL
mg/m	NULL
!	NULL
)	NULL

for	NULL
4	NULL
h.	NULL
Formazan	NULL
crystals	NULL
formed	NULL
during	NULL
incubation	NULL
were	NULL
then	NULL
dissolved	NULL
by	NULL
addition	NULL
of	NULL
0.1	NULL
n	NULL
HCI	NULL
in	NULL
an	NULL
amount	NULL
equal	NULL
to	NULL
the	NULL
culture	NULL
volume	NULL
,	NULL
and	NULL
the	NULL
absorbance	NULL
was	NULL
spectrophotometri-cally	NULL
measured	NULL
at	NULL
a	NULL
wavelength	NULL
of	NULL
570	NULL
nm	NULL
.	NULL

All	NULL
assays	NULL
were	NULL
performed	NULL
in	NULL
duplicate	NULL
.	NULL

As	NULL
controlled	NULL
by	NULL
polyacrylamide	NULL
get	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
electrophoresis	NULL
,	NULL
undegraded	NULL
radiolabeled	NULL
otigonuctieotides	NULL
were	NULL
still	NULL
detectable	NULL
in	NULL
both	NULL
culture	NULL
medium	NULL
and	NULL
cytosol	NULL
at	NULL
least	NULL
after	NULL
4	NULL
h.	NULL
Oligodeoxynucleotides	NULL
.	NULL

Oligodeoxynucleotides	NULL
_	NULL
were	NULL
synthesized	NULL
on	NULL
a	NULL
380B	NULL
DNA	NULL
synthesizer	NULL
(	NULL
Applied	NULL
Biosys-tems	NULL
)	NULL
.	NULL

Volatile	NULL
organic	NULL
contaminants	NULL
were	NULL
removed	NULL
by	NULL
Speed-Vac	NULL
lyophilization	NULL
and	NULL
three	NULL
cycles	NULL
of	NULL
dilution	NULL
in	NULL
pure	NULL
water	NULL
.	NULL

The	NULL
absence	NULL
of	NULL
incomplete	NULL
oligomers	NULL
was	NULL
checked	NULL
by	NULL
denaturing	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
.	NULL

The	NULL
double-stranded	NULL
oligonucleotide	NULL
probe	NULL
containing	NULL
the	NULL
IL-2Ra	NULL
promoter	NULL
NF-	NULL
«	NULL
B-binding	NULL
site	NULL
(	NULL
«	NULL
Bi	NULL
.	NULL

>	NULL
r	NULL
,	NULL
,	NULL
under-lined	NULL
)	NULL
(	NULL
56	NULL
)	NULL
used	NULL
in	NULL
EMSA	NULL
was	NULL
:	NULL
5'-	NULL
CAACGGCAGGGGAATCTCCCTCTCCTT-3	NULL
'	NULL
3	NULL
``	NULL
Single-strand	NULL
oligodeoxynucleotides	NULL
used	NULL
in	NULL
T-cell	NULL
cultures	NULL
were	NULL
:	NULL
Human	NULL
NF-	NULL
«	NULL
B1	NULL
sense	NULL
:	NULL
5-GGCTTCAGAATGGCAGAAGA-3	NULL
'	NULL
antisense	NULL
:	NULL
5'-ATCTICTGCCATTCTGAAGCC-3	NULL
'	NULL
Human	NULL
Re/A	NULL
(	NULL
p65	NULL
)	NULL
sense	NULL
:	NULL
5-CGGCCATGGACGAACTGTTC-3	NULL
'	NULL
antisense	NULL
:	NULL
5'-GAACAGTTCGTCCATGGCCG-3	NULL
'	NULL
These	NULL
inhibitory	NULL
oligodeoxynucleotides	NULL
extending	NULL
over	NULL
the	NULL
translational	NULL
initiation	NULL
sites	NULL
(	NULL
underlined	NULL
)	NULL
were	NULL
designed	NULL
according	NULL
to	NULL
Kitajima	NULL
et	NULL
al	NULL
.	NULL

(	NULL
57	NULL
)	NULL
but	NULL
adapted	NULL
to	NULL
human	NULL
gene	NULL
sequences	NULL
and	NULL
without	NULL
phosphorothioate	NULL
modification	NULL
.	NULL

Flow	NULL
Cytometry	NULL
.	NULL

CD25/IL-2Ra	NULL
cell	NULL
surface	NULL
expression	NULL
was	NULL
detected	NULL
according	NULL
to	NULL
standard	NULL
procedures	NULL
with	NULL
fluo-rescein	NULL
isothiocyanate-labeled	NULL
antibody	NULL
33B3.1	NULL
(	NULL
68	NULL
)	NULL
using	NULL
a	NULL
FACSCAN	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
.	NULL

Specific	NULL
Antisera	NULL
and	NULL
Recombinant	NULL
Protein	NULL
.	NULL

Rabbit	NULL
sera	NULL
no	NULL
.	NULL

2	NULL
and	NULL
no	NULL
.	NULL

3	NULL
(	NULL
22	NULL
)	NULL
are	NULL
directed	NULL
against	NULL
fusion	NULL
proteins	NULL
containing	NULL
amino	NULL
acids	NULL
19	NULL
to	NULL
969	NULL
and	NULL
19	NULL
to	NULL
502	NULL
of	NULL
p50/p65	NULL
,	NULL
respectively	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
A.	NULL
Israél	NULL
,	NULL
U277	NULL
IN-SERM	NULL
,	NULL
Paris	NULL
,	NULL
France	NULL
)	NULL
.	NULL

Antiserum	NULL
no	NULL
.	NULL

2	NULL
recognizes	NULL
both	NULL
KBF1/	NULL
p50	NULL
homodimer	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
p50/p105	NULL
heterodimer	NULL
.	NULL

Antiserum	NULL
no	NULL
.	NULL

3	NULL
recognizes	NULL
only	NULL
KBF1/p50	NULL
homodimer	NULL
.	NULL

Purified	NULL
rabbit	NULL
serum	NULL
anti-p50N	NULL
is	NULL
directed	NULL
against	NULL
a	NULL
p50	NULL
NH	NULL
;	NULL
-terminal	NULL
peptide	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
69	NULL
)	NULL
.	NULL

Bacterial	NULL
extract	NULL
containing	NULL
MAD-3/l	NULL
«	NULL
kBa	NULL
was	NULL
obtained	NULL
from	NULL
T.	NULL
Henkel	NULL
(	NULL
Laboratorium	NULL
fiir	NULL
Molekulare	NULL
Biologie	NULL
,	NULL
Genzentrum	NULL
,	NULL
Martinsried	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
Dr.	NULL
Alain	NULL
Israél	NULL
for	NULL
providing	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
antisera	NULL
,	NULL
Francoise	NULL
Mallet	NULL
for	NULL
helpful	NULL
technical	NULL
assistance	NULL
,	NULL
Nicolas	NULL
Maroc	NULL
for	NULL
helpful	NULL
discussion	NULL
,	NULL
and	NULL
Drs	NULL
.	NULL

Alain	NULL
Israél	NULL
,	NULL
Pierre	NULL
Golstein	NULL
,	NULL
and	NULL
Claude	NULL
Mawas	NULL
for	NULL
invaluable	NULL
advice	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Damle	NULL
,	NULL
N.	NULL
K.	NULL
,	NULL
Mohagheghpour	NULL
,	NULL
N.	NULL
,	NULL
Hansen	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Engleman	NULL
,	NULL
E.	NULL
G.	NULL
Alloantigen-specific	NULL
cytotoxic	NULL
and	NULL
suppressor	NULL
T	NULL
lymphocytes	NULL
are	NULL
derived	NULL
from	NULL
phenotypically	NULL
distinct	NULL
precursors	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
137	NULL
:	NULL
2296-2300	NULL
,	NULL
1983	NULL
.	NULL

2	NULL
.	NULL

Clark	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
Ledbetter	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Holly	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
Dinndorf	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Shu	NULL
,	NULL
G.	NULL
Polypeptides	NULL
on	NULL
human	NULL
B	NULL
lymphocytes	NULL
associated	NULL
with	NULL
cell	NULL
activation	NULL
.	NULL

Hum	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
76	NULL
:	NULL
100-113	NULL
,	NULL
1986	NULL
.	NULL

3	NULL
.	NULL

Linsley	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
Clark	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
and	NULL
Ledbetter	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
T-cell	NULL
antigen	NULL
CD28	NULL
mediates	NULL
adhesion	NULL
with	NULL
B	NULL
cells	NULL
by	NULL
interacting	NULL
with	NULL
activation	NULL
antigen	NULL
B7/8B-1	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
87	NULL
:	NULL
5031-5035	NULL
,	NULL
1990	NULL
.	NULL

4	NULL
.	NULL

Selvaraj	NULL
,	NULL
P.	NULL
,	NULL
Plunkett	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
Dustin	NULL
,	NULL
M.	NULL
,	NULL
Sanders	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
Shaw	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Springer	NULL
,	NULL
T.	NULL
A	NULL
.	NULL

The	NULL
T	NULL
lymphocyte	NULL
glycoprotein	NULL
CD2	NULL
(	NULL
LFA-2/11	NULL
1/E-rosette	NULL
receptor	NULL
)	NULL
binds	NULL
the	NULL
cell	NULL
surface	NULL
ligand	NULL
LFA-3	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
326	NULL
:	NULL
400-403	NULL
,	NULL
1987	NULL
.	NULL

5	NULL
.	NULL

Denning	NULL
,	NULL
S.	NULL
,	NULL
Dustin	NULL
,	NULL
M.	NULL
,	NULL
Springer	NULL
,	NULL
T.	NULL
,	NULL
Singer	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Haynes	NULL
,	NULL
B.	NULL
Purified	NULL
lymphocyte	NULL
function	NULL
associated	NULL
antigen-3	NULL
(	NULL
LFA-3	NULL
)	NULL
activates	NULL
human	NULL
thymocytes	NULL
via	NULL
the	NULL
CD2	NULL
pathway	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
147	NULL
:	NULL
2980-2985	NULL
,	NULL
1988	NULL
.	NULL

6	NULL
.	NULL

Vollger	NULL
,	NULL
L.	NULL
W.	NULL
,	NULL
Tuck	NULL
,	NULL
D.	NULL
T.	NULL
,	NULL
Springer	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
Haynes	NULL
,	NULL
B.	NULL
F.	NULL
,	NULL
and	NULL
Singer	NULL
,	NULL
K.	NULL
H.	NULL
Thymocyte	NULL
binding	NULL
to	NULL
human	NULL
thymic	NULL
epithelial	NULL
cells	NULL
is	NULL
inhibited	NULL
by	NULL
monoclonal	NULL
antibodies	NULL
to	NULL
CD-2	NULL
and	NULL
LFA-3	NULL
antigens	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
138	NULL
:	NULL
358	NULL
,	NULL
1987	NULL
.	NULL

7	NULL
.	NULL

Hahn	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
Menu	NULL
,	NULL
E.	NULL
,	NULL
Bothwell	NULL
,	NULL
A.	NULL
L.	NULL
M.	NULL
,	NULL
Sims	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
and	NULL
Bierer	NULL
,	NULL
B.	NULL
E.	NULL
Overlapping	NULL
but	NULL
nonidentical	NULL
binding	NULL
sites	NULL
on	NULL
CD2	NULL
for	NULL
CD58	NULL
and	NULL
a	NULL
second	NULL
ligand	NULL
CD59	NULL
.	NULL

Science	NULL
(	NULL
Washington	NULL
DC	NULL
)	NULL
,	NULL
256	NULL
:	NULL
1805-1807	NULL
,	NULL
1992	NULL
.	NULL

8	NULL
.	NULL

Kato	NULL
,	NULL
K.	NULL
,	NULL
Koyanagi	NULL
,	NULL
M.	NULL
,	NULL
Okada	NULL
,	NULL
H.	NULL
,	NULL
Takanashi	NULL
,	NULL
T.	NULL
,	NULL
Wah	NULL
Wong	NULL
,	NULL
Y.	NULL
,	NULL
Willi-ams	NULL
,	NULL
A.	NULL
F.	NULL
,	NULL
Okumura	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Yagita	NULL
,	NULL
H.	NULL
CD48	NULL
is	NULL
a	NULL
counter-receptor	NULL
for	NULL
mouse	NULL
CD2	NULL
and	NULL
is	NULL
involved	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
176	NULL
:	NULL
1241-1249	NULL
,	NULL
1992	NULL
.	NULL

9	NULL
.	NULL

Cerdan	NULL
,	NULL
C.	NULL
,	NULL
Martin	NULL
,	NULL
Y.	NULL
,	NULL
Courcoul	NULL
,	NULL
M.	NULL
,	NULL
Mawas	NULL
,	NULL
C.	NULL
,	NULL
Birg	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Olive	NULL
,	NULL
D.	NULL
Prolonged	NULL
IL-2	NULL
receptor	NULL
a/CD25	NULL
expression	NULL
after	NULL
T	NULL
cell	NULL
activation	NULL
via	NULL
the	NULL
adhesion	NULL
molecules	NULL
CD2	NULL
and	NULL
CD28	NULL
:	NULL
demonstration	NULL
of	NULL
combined	NULL
transcriptional	NULL
and	NULL
post	NULL
transcriptional	NULL
regulation	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
149	NULL
:	NULL
2255-2261	NULL
,	NULL
1992	NULL
.	NULL

10	NULL
.	NULL

Pierres	NULL
,	NULL
A.	NULL
,	NULL
Lopez	NULL
,	NULL
M.	NULL
,	NULL
Cerdan	NULL
,	NULL
C.	NULL
,	NULL
Nunes	NULL
,	NULL
J.	NULL
,	NULL
Olive	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Mawas	NULL
,	NULL
C.	NULL
Triggering	NULL
CD28	NULL
molecules	NULL
synergize	NULL
with	NULL
CD2	NULL
(	NULL
T11.1	NULL
and	NULL
T11.2	NULL
)	NULL
-mediated	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Eur	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
18	NULL
:	NULL
685-690	NULL
,	NULL
1988	NULL
.	NULL

11	NULL
.	NULL

Van-Lier	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Brouwer	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Aarden	NULL
,	NULL
L.	NULL
A	NULL
.	NULL

Signals	NULL
involved	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
:	NULL
T	NULL
cell	NULL
proliferation	NULL
induced	NULL
through	NULL
the	NULL
synergistic	NULL
action	NULL
of	NULL
anti-CD28	NULL
and	NULL
anti-CD2	NULL
monoclonal	NULL
antibodies	NULL
.	NULL

Eur	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
18	NULL
:	NULL
167-172	NULL
,	NULL
1988	NULL
.	NULL

12	NULL
.	NULL

Costello	NULL
,	NULL
R.	NULL
,	NULL
Cerdan	NULL
,	NULL
C.	NULL
,	NULL
Pavon	NULL
,	NULL
C.	NULL
,	NULL
Brailly	NULL
,	NULL
H.	NULL
,	NULL
Hurpin	NULL
,	NULL
C.	NULL
,	NULL
Mawas	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Olive	NULL
,	NULL
D.	NULL
The	NULL
CD2	NULL
and	NULL
CD28	NULL
adhesion	NULL
molecules	NULL
induce	NULL
long-term	NULL
autocrine	NULL
proliferation	NULL
of	NULL
CD4+	NULL
T	NULL
cells	NULL
.	NULL

Eur	NULL
.	NULL
}	NULL

.	NULL

Immunol	NULL
.	NULL

,	NULL
23:608-613	NULL
,	NULL
1993	NULL
.	NULL

13	NULL
.	NULL

Lindsten	NULL
,	NULL
T.	NULL
,	NULL
June	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
Ledbetter	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Stella	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Thompson	NULL
,	NULL
C.	NULL
B	NULL
.	NULL

Regulation	NULL
of	NULL
lymphokine	NULL
mRNA	NULL
stability	NULL
by	NULL
a	NULL
surface-mediated	NULL
T	NULL
cell	NULL
activation	NULL
pathway	NULL
.	NULL

Science	NULL
(	NULL
Washington	NULL
DC	NULL
)	NULL
,	NULL
244	NULL
:	NULL
339-343	NULL
,	NULL
1989	NULL
.	NULL

14	NULL
.	NULL

Fraser	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Irving	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
and	NULL
Weiss	NULL
,	NULL
A	NULL
.	NULL

Regulation	NULL
of	NULL
interleukin-2	NULL
gene	NULL
enhancer	NULL
activity	NULL
by	NULL
the	NULL
T	NULL
cell	NULL
accessory	NULL
molecule	NULL
CD28	NULL
.	NULL

Science	NULL
(	NULL
Washington	NULL
DC	NULL
)	NULL
,	NULL
257	NULL
;	NULL
313-316	NULL
,	NULL
1991	NULL
.	NULL

15	NULL
.	NULL

Verweij	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
Geerts	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Aarden	NULL
,	NULL
L.	NULL
A.	NULL
Activation	NULL
of	NULL
interleukin-2	NULL
gene	NULL
transcription	NULL
via	NULL
the	NULL
T-cell	NULL
surface	NULL
molecule	NULL
CD28	NULL
is	NULL
mediated	NULL
through	NULL
an	NULL
NF-xB-like	NULL
response	NULL
element	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
266	NULL
:	NULL
14179-14182	NULL
,	NULL
1991	NULL
.	NULL

16	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

The	NULL
inducible	NULL
transcription	NULL
activator	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
regulation	NULL
by	NULL
distinct	NULL
protein	NULL
subunits	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
,	NULL
1072	NULL
:	NULL
63-80	NULL
,	NULL
1991	NULL
.	NULL

17	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
IxB	NULL
:	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
the	NULL
NF-xB	NULL
transcription	NULL
factor	NULL
.	NULL

Science	NULL
(	NULL
Washington	NULL
DC	NULL
)	NULL
,	NULL
242	NULL
:	NULL
540-546	NULL
,	NULL
1988	NULL
.	NULL

18	NULL
.	NULL

Urban	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
and	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

The	NULL
65-kD	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
a	NULL
receptor	NULL
for	NULL
IxB	NULL
and	NULL
a	NULL
modulator	NULL
of	NULL
DNA-binding	NULL
specificity	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

,	NULL
4	NULL
:	NULL
1975-1984	NULL
,	NULL
1990	NULL
.	NULL

19	NULL
.	NULL

Sen	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
inducibility	NULL
of	NULL
«	NULL
immunoglobulin	NULL
enhancer-binding	NULL
protein	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
a	NULL
posttranslational	NULL
mechanism	NULL
.	NULL

Cell	NULL
,	NULL
47:921-928	NULL
,	NULL
1986	NULL
.	NULL

20	NULL
.	NULL

Urban	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
and	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

The	NULL
role	NULL
of	NULL
the	NULL
p50	NULL
and	NULL
p65	NULL
subunits	NULL
of	NULL
NF-xB	NULL
in	NULL
the	NULL
recognition	NULL
of	NULL
cognate	NULL
sequences	NULL
.	NULL

New	NULL
Biol	NULL
.	NULL

,	NULL
3	NULL
:	NULL
279-288	NULL
,	NULL
1991	NULL
.	NULL

21	NULL
.	NULL

Ghosh	NULL
,	NULL
S.	NULL
,	NULL
Gifford	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Riviere	NULL
,	NULL
L.	NULL
R.	NULL
,	NULL
Tempst	NULL
,	NULL
P.	NULL
,	NULL
Nolan	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
Cloning	NULL
of	NULL
the	NULL
p50	NULL
DNA	NULL
binding	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
homology	NULL
to	NULL
rel	NULL
and	NULL
dorsal	NULL
.	NULL

Cell	NULL
,	NULL
62	NULL
:	NULL
1019-1029	NULL
,	NULL
1990	NULL
.	NULL

22	NULL
.	NULL

Kieran	NULL
,	NULL
M.	NULL
,	NULL
Blank	NULL
,	NULL
V.	NULL
,	NULL
Logeat	NULL
,	NULL
F.	NULL
,	NULL
Vandekerckhove	NULL
,	NULL
J.	NULL
,	NULL
Lottspeich	NULL
,	NULL
F.	NULL
,	NULL
Le-Bail	NULL
,	NULL
O.	NULL
,	NULL
Urban	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
Kourilsky	NULL
,	NULL
P.	NULL
,	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Israel	NULL
,	NULL
A	NULL
.	NULL

The	NULL
DNA	NULL
binding	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
identical	NULL
to	NULL
factor	NULL
KBF1	NULL
and	NULL
homologous	NULL
to	NULL
the	NULL
rel	NULL
oncogene	NULL
product	NULL
.	NULL

Cell	NULL
,	NULL
62	NULL
:	NULL
1007-1018	NULL
,	NULL
1990	NULL
.	NULL

23	NULL
.	NULL

Riviere	NULL
,	NULL
Y.	NULL
,	NULL
Blank	NULL
,	NULL
V.	NULL
,	NULL
Kourilsky	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Israél	NULL
,	NULL
A	NULL
.	NULL

Processing	NULL
of	NULL
the	NULL
precursor	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
the	NULL
HIV-1	NULL
protease	NULL
during	NULL
acute	NULL
infection	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
350	NULL
:	NULL
625-626	NULL
,	NULL
1991	NULL
.	NULL

24	NULL
.	NULL

Fan	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
Generation	NULL
of	NULL
p50	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
processing	NULL
of	NULL
p105	NULL
through	NULL
an	NULL
ATP-dependent	NULL
pathway	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
354	NULL
:	NULL
395-398	NULL
,	NULL
1991	NULL
.	NULL

25	NULL
.	NULL

Henkel	NULL
,	NULL
T.	NULL
,	NULL
Zabel	NULL
,	NULL
U.	NULL
,	NULL
van-Zee	NULL
,	NULL
K.	NULL
,	NULL
Muller	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Fanning	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
Intramolecular	NULL
masking	NULL
of	NULL
the	NULL
nuclear	NULL
location	NULL
signal	NULL
and	NULL
dimer-ization	NULL
domain	NULL
in	NULL
the	NULL
precursor	NULL
for	NULL
the	NULL
p50	NULL
NF-	NULL
«	NULL
B	NULL
subunit	NULL
.	NULL

Cell	NULL
,	NULL
68	NULL
:	NULL
1121-1133	NULL
,	NULL
1992	NULL
.	NULL

26	NULL
.	NULL

Rice	NULL
,	NULL
N.	NULL
R.	NULL
,	NULL
MacKichan	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
and	NULL
Israél	NULL
,	NULL
A	NULL
.	NULL

The	NULL
precursor	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
has	NULL
IxB-like	NULL
functions	NULL
.	NULL

Cell	NULL
,	NULL
77	NULL
;	NULL
243-253	NULL
,	NULL
1992	NULL
.	NULL

27	NULL
.	NULL

Blank	NULL
,	NULL
V.	NULL
,	NULL
Kourilsky	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Israél	NULL
,	NULL
A.	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
related	NULL
proteins	NULL
:	NULL
Rel/	NULL
dorsal	NULL
homologies	NULL
meet	NULL
ankyrin-like	NULL
repeats	NULL
.	NULL

Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

,	NULL
17	NULL
:	NULL
135-140	NULL
,	NULL
1992	NULL
.	NULL

28	NULL
.	NULL

Grimm	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

The	NULL
inducible	NULL
transcription	NULL
factor	NULL
NF-xB	NULL
:	NULL
structure-function	NULL
relationship	NULL
of	NULL
its	NULL
protein	NULL
subunits	NULL
.	NULL

Biochem	NULL
.	NULL

J.	NULL
,	NULL
290	NULL
:	NULL
297-308	NULL
,	NULL
1993	NULL
.	NULL

29	NULL
.	NULL

Fujita	NULL
,	NULL
T.	NULL
,	NULL
Nolan	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
Ghosh	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
Independent	NULL
modes	NULL
of	NULL
transcriptional	NULL
activation	NULL
by	NULL
the	NULL
p50	NULL
and	NULL
p65	NULL
subunits	NULL
of	NULL
NF-kB	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

,	NULL
6	NULL
:	NULL
775-787	NULL
,	NULL
1992	NULL
.	NULL

30	NULL
.	NULL

Kunsch	NULL
,	NULL
C.	NULL
,	NULL
Ruben	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
and	NULL
Rosen	NULL
,	NULL
G.	NULL
A	NULL
.	NULL

Selection	NULL
of	NULL
optimal	NULL
«	NULL
B/Re	NULL
!	NULL

953	NULL
954	NULL
Role	NULL
of	NULL
NF-kB1	NULL
Gene	NULL
in	NULL
CD2+CD28	NULL
Activation	NULL
DNA-binding	NULL
motifs	NULL
:	NULL
interaction	NULL
of	NULL
both	NULL
subunits	NULL
of	NULL
NF-xB	NULL
with	NULL
DNA	NULL
is	NULL
required	NULL
for	NULL
transcriptional	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
12	NULL
:	NULL
4412-4421	NULL
,	NULL
1992	NULL
.	NULL

31	NULL
.	NULL

Perkins	NULL
,	NULL
N.	NULL
D.	NULL
,	NULL
Schmid	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Duckett	NULL
,	NULL
C.	NULL
S.	NULL
,	NULL
Leung	NULL
,	NULL
K.	NULL
,	NULL
Rice	NULL
,	NULL
N.	NULL
R.	NULL
,	NULL
and	NULL
Nabel	NULL
,	NULL
G.	NULL
}	NULL
.	NULL

Distinct	NULL
combinations	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
subunits	NULL
determine	NULL
the	NULL
specificity	NULL
of	NULL
transcriptional	NULL
activation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
89	NULL
:	NULL
1529-1533	NULL
,	NULL
1992	NULL
.	NULL

32	NULL
.	NULL

Kang	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Tran	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
Grilli	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Lenardo	NULL
,	NULL
M.	NULL
J.	NULL
NF-	NULL
«	NULL
B	NULL
subunit	NULL
regulation	NULL
in	NULL
nontransformed	NULL
CD4+	NULL
T	NULL
lymphocytes	NULL
.	NULL

Science	NULL
(	NULL
Washington	NULL
DC	NULL
)	NULL
,	NULL
256	NULL
:	NULL
1452-1456	NULL
,	NULL
1992	NULL
.	NULL

33	NULL
.	NULL

Arima	NULL
,	NULL
N.	NULL
,	NULL
Kuziel	NULL
,	NULL
W.	NULL
A.	NULL
,	NULL
Grdina	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
IL-2-induced	NULL
signal	NULL
transduction	NULL
involves	NULL
the	NULL
activation	NULL
of	NULL
nuclear	NULL
NF-kB	NULL
expression	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
149	NULL
:	NULL
83-91	NULL
,	NULL
1992	NULL
.	NULL

34	NULL
.	NULL

Granelli-Piperno	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Nolan	NULL
,	NULL
P.	NULL
Nuclear	NULL
transcription	NULL
factors	NULL
that	NULL
bind	NULL
to	NULL
elements	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
:	NULL
induction	NULL
requirements	NULL
in	NULL
primary	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
147	NULL
:	NULL
2734-2739	NULL
,	NULL
1991	NULL
.	NULL

35	NULL
.	NULL

Lowenthal	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Bohnlein	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
Tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
induces	NULL
proteins	NULL
that	NULL
bind	NULL
specifically	NULL
to	NULL
«	NULL
B-like	NULL
enhancer	NULL
elements	NULL
and	NULL
regulate	NULL
interleukin	NULL
2	NULL
receptor	NULL
a-chain	NULL
gene	NULL
expression	NULL
in	NULL
primary	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
86	NULL
:	NULL
2331-2335	NULL
,	NULL
1989	NULL
.	NULL

36	NULL
.	NULL

Ghosh	NULL
,	NULL
P.	NULL
,	NULL
Tan	NULL
,	NULL
T.	NULL
H.	NULL
,	NULL
Rice	NULL
,	NULL
N.	NULL
R.	NULL
,	NULL
Sica	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Young	NULL
,	NULL
H.	NULL
A	NULL
.	NULL

The	NULL
interleukin	NULL
2	NULL
CD28-responsive	NULL
complex	NULL
contains	NULL
at	NULL
least	NULL
three	NULL
members	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
family	NULL
:	NULL
c-Rel	NULL
,	NULL
p50	NULL
,	NULL
and	NULL
p65	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
90	NULL
:	NULL
1696-1700	NULL
,	NULL
1993	NULL
.	NULL

37	NULL
.	NULL

Grilli	NULL
,	NULL
M.	NULL
,	NULL
Chiu	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
and	NULL
Lenardo	NULL
,	NULL
M.	NULL
J.	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
Rel	NULL
:	NULL
participants	NULL
in	NULL
a	NULL
multiform	NULL
transcriptional	NULL
regulatory	NULL
system	NULL
.	NULL

Int	NULL
.	NULL

Rev	NULL
.	NULL

Cytol	NULL
.	NULL

,	NULL
143	NULL
:	NULL
1-62	NULL
,	NULL
1993	NULL
.	NULL

38	NULL
.	NULL

Sanders	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
Makgoba	NULL
,	NULL
M.	NULL
W.	NULL
,	NULL
Sharrow	NULL
,	NULL
S.	NULL
O.	NULL
,	NULL
Stephany	NULL
,	NULL
D.	NULL
,	NULL
Springer	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
Young	NULL
,	NULL
H.	NULL
A.	NULL
,	NULL
and	NULL
Shaw	NULL
,	NULL
S.	NULL
Human	NULL
memory	NULL
T	NULL
lymphocytes	NULL
express	NULL
increased	NULL
levels	NULL
of	NULL
three	NULL
cell	NULL
adhesion	NULL
molecules	NULL
(	NULL
LFA-3	NULL
,	NULL
CD2	NULL
,	NULL
and	NULL
LFA-1	NULL
)	NULL
and	NULL
three	NULL
other	NULL
molecules	NULL
(	NULL
UCHL1	NULL
,	NULL
CDWw29	NULL
,	NULL
and	NULL
Pgp-1	NULL
)	NULL
and	NULL
have	NULL
enhanced	NULL
IFN	NULL
y	NULL
production	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
140	NULL
;	NULL
1401-1407	NULL
,	NULL
1988	NULL
.	NULL

39	NULL
.	NULL

Kelso	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Gough	NULL
,	NULL
N.	NULL
M.	NULL
Coexpression	NULL
of	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
,	NULL
y	NULL
interferon	NULL
,	NULL
and	NULL
interleukins	NULL
3	NULL
and	NULL
4	NULL
is	NULL
random	NULL
in	NULL
murine	NULL
alloreactive	NULL
T-lymphocyte	NULL
clones	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
85	NULL
:	NULL
9189-9193	NULL
,	NULL
1988	NULL
.	NULL

40	NULL
.	NULL

Noma	NULL
,	NULL
T.	NULL
,	NULL
Nakakubo	NULL
,	NULL
H.	NULL
,	NULL
Sugita	NULL
,	NULL
M.	NULL
,	NULL
Kumagai	NULL
,	NULL
S.	NULL
,	NULL
Maeda	NULL
,	NULL
M.	NULL
,	NULL
Shimizu	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Honjo	NULL
,	NULL
T.	NULL
Expression	NULL
of	NULL
different	NULL
combinations	NULL
of	NULL
interleukins	NULL
by	NULL
human	NULL
T	NULL
cell	NULL
leukemic	NULL
cell	NULL
lines	NULL
that	NULL
are	NULL
clonally	NULL
related	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
169	NULL
;	NULL
1853-1858	NULL
,	NULL
1989	NULL
.	NULL

41	NULL
.	NULL

Carding	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
Jenkinson	NULL
,	NULL
E.	NULL
J.	NULL
,	NULL
Kingston	NULL
,	NULL
R.	NULL
,	NULL
Hayday	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
Bottomly	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Owen	NULL
,	NULL
J.	NULL
J.	NULL
Developmental	NULL
control	NULL
of	NULL
lymphokine	NULL
gene	NULL
expression	NULL
in	NULL
fetal	NULL
thymocytes	NULL
during	NULL
T-cell	NULL
ontogeny	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
86	NULL
:	NULL
3342-3345	NULL
,	NULL
1989	NULL
.	NULL

42	NULL
.	NULL

Salmon	NULL
,	NULL
M.	NULL
,	NULL
Kitas	NULL
,	NULL
G.	NULL
D.	NULL
,	NULL
and	NULL
Bacon	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

Production	NULL
of	NULL
lymphokine	NULL
mRNA	NULL
by	NULL
CD45R+	NULL
and	NULL
CD45R-	NULL
helper	NULL
T	NULL
cells	NULL
from	NULL
human	NULL
peripheral	NULL
blood	NULL
and	NULL
by	NULL
human	NULL
CD4+	NULL
T	NULL
cell	NULL
clones	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
143	NULL
;	NULL
907-912	NULL
,	NULL
1989	NULL
.	NULL

43	NULL
.	NULL

Costello	NULL
,	NULL
R.	NULL
,	NULL
Lipcey	NULL
,	NULL
C.	NULL
,	NULL
Algarté	NULL
,	NULL
M.	NULL
,	NULL
Cerdan	NULL
,	NULL
C.	NULL
,	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Olive	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Imbert	NULL
,	NULL
J.	NULL
Activation	NULL
of	NULL
primary	NULL
human	NULL
T-lymphocytes	NULL
through	NULL
CD2	NULL
plus	NULL
CD28	NULL
adhesion	NULL
molecules	NULL
induces	NULL
long-term	NULL
nuclear	NULL
expression	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Cell	NULL
Growth	NULL
&	NULL
Differ	NULL
.	NULL

,	NULL
4	NULL
:	NULL
329-339	NULL
,	NULL
1993	NULL
.	NULL

44	NULL
.	NULL

Mercurio	NULL
,	NULL
F.	NULL
,	NULL
DiDonato	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Rosette	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
p105	NULL
and	NULL
p98	NULL
precursor	NULL
proteins	NULL
play	NULL
an	NULL
active	NULL
role	NULL
in	NULL
NF-	NULL
«	NULL
B-mediated	NULL
signal	NULL
transduction	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

,	NULL
7	NULL
:	NULL
705-718	NULL
,	NULL
1993	NULL
.	NULL

45	NULL
.	NULL

Blank	NULL
,	NULL
V.	NULL
,	NULL
Kourilsky	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
A.	NULL
Cytoplasmic	NULL
retention	NULL
,	NULL
DNA	NULL
binding	NULL
and	NULL
processing	NULL
of	NULL
the	NULL
NF-kB	NULL
p50	NULL
precursor	NULL
are	NULL
controlled	NULL
by	NULL
a	NULL
small	NULL
region	NULL
in	NULL
its	NULL
C-terminus	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
10	NULL
:	NULL
4159-4167	NULL
,	NULL
1991	NULL
.	NULL

46	NULL
.	NULL

Haskill	NULL
,	NULL
S.	NULL
,	NULL
Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
Tompkins	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Morris	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Yurochko	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
Sampson-Johannes	NULL
,	NULL
A.	NULL
,	NULL
Mondal	NULL
,	NULL
K.	NULL
,	NULL
Ralph	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
J	NULL
.	NULL

Characterization	NULL
of	NULL
an	NULL
immediate-early	NULL
gene	NULL
induced	NULL
in	NULL
adherent	NULL
monocytes	NULL
that	NULL
encodes	NULL
IkB-like	NULL
activity	NULL
.	NULL

Cell	NULL
,	NULL
65	NULL
:	NULL
1281-1289	NULL
,	NULL
1991	NULL
.	NULL

47	NULL
.	NULL

Muegge	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Durum	NULL
,	NULL
S.	NULL
K.	NULL
From	NULL
cell	NULL
code	NULL
to	NULL
gene	NULL
code	NULL
:	NULL
cytokines	NULL
and	NULL
transcription	NULL
factors	NULL
.	NULL

New	NULL
Biol	NULL
.	NULL

,	NULL
1	NULL
:	NULL
239-247	NULL
,	NULL
1989	NULL
.	NULL

48	NULL
.	NULL

Ten	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Paya	NULL
,	NULL
C.	NULL
V.	NULL
,	NULL
Israél	NULL
,	NULL
N.	NULL
,	NULL
Le-Bail	NULL
,	NULL
O.	NULL
,	NULL
Mattei	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
Virelizier	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Kourilsky	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Israél	NULL
,	NULL
A	NULL
.	NULL

The	NULL
characterization	NULL
of	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
gene	NULL
encoding	NULL
the	NULL
p50	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
indicates	NULL
that	NULL
it	NULL
participates	NULL
in	NULL
its	NULL
own	NULL
regulation	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
17	NULL
:	NULL
195-203	NULL
,	NULL
1992	NULL
.	NULL

49	NULL
.	NULL

Cogswell	NULL
,	NULL
P.	NULL
C.	NULL
,	NULL
Scheinman	NULL
,	NULL
R.	NULL
I.	NULL
,	NULL
and	NULL
Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Jr	NULL
.	NULL

Promoter	NULL
of	NULL
the	NULL
human	NULL
NF-	NULL
«	NULL
B	NULL
p50/p105	NULL
gene	NULL
:	NULL
regulation	NULL
by	NULL
NF-xB	NULL
subunits	NULL
and	NULL
by	NULL
c-REL	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
150	NULL
:	NULL
2794-2804	NULL
,	NULL
1993	NULL
.	NULL

50	NULL
.	NULL

Inoue	NULL
,	NULL
J.	NULL
,	NULL
Kerr	NULL
,	NULL
L.	NULL
D.	NULL
,	NULL
Kakizuka	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Verma	NULL
,	NULL
|	NULL
.	NULL

M.	NULL
IB	NULL
y	NULL
,	NULL
a	NULL
70	NULL
kd	NULL
protein	NULL
identical	NULL
to	NULL
the	NULL
C-terminal	NULL
half	NULL
of	NULL
p110	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
a	NULL
new	NULL
member	NULL
of	NULL
the	NULL
IB	NULL
family	NULL
.	NULL

Cell	NULL
,	NULL
68	NULL
:	NULL
1109-1120	NULL
,	NULL
1992	NULL
.	NULL

51	NULL
.	NULL

Hatada	NULL
,	NULL
E.	NULL
N.	NULL
,	NULL
Nieters	NULL
,	NULL
A.	NULL
,	NULL
Wulczyn	NULL
,	NULL
F.	NULL
G.	NULL
,	NULL
Naumann	NULL
,	NULL
M.	NULL
,	NULL
Meyer	NULL
,	NULL
R.	NULL
,	NULL
Nucifora	NULL
,	NULL
G.	NULL
,	NULL
McKeithan	NULL
,	NULL
T.	NULL
W.	NULL
,	NULL
and	NULL
Scheidereit	NULL
,	NULL
C.	NULL
The	NULL
ankyrin	NULL
repeat	NULL
domains	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
precursor	NULL
p105	NULL
and	NULL
the	NULL
protooncogene	NULL
bel-3	NULL
act	NULL
as	NULL
specific	NULL
inhibitors	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
DNA	NULL
binding	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
89	NULL
:	NULL
2489-2493	NULL
,	NULL
1992	NULL
.	NULL

52	NULL
.	NULL

Helene	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Toulme	NULL
,	NULL
J-	NULL
)	NULL
.	NULL

Specific	NULL
regulation	NULL
of	NULL
gene	NULL
expression	NULL
by	NULL
antisense	NULL
,	NULL
sense	NULL
and	NULL
antigene	NULL
nucleic	NULL
acids	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
,	NULL
1049	NULL
;	NULL
99-125	NULL
,	NULL
1990	NULL
.	NULL

53	NULL
.	NULL

Cross	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Halden	NULL
,	NULL
N.	NULL
F.	NULL
,	NULL
Lenardo	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
Leonard	NULL
,	NULL
W.	NULL
J.	NULL
Functionally	NULL
distinct	NULL
NF-kB	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
immunoglobulin	NULL
k	NULL
and	NULL
IL-2	NULL
receptor	NULL
a	NULL
chain	NULL
genes	NULL
.	NULL

Science	NULL
(	NULL
Washington	NULL
DC	NULL
)	NULL
,	NULL
244	NULL
:	NULL
466-469	NULL
,	NULL
1989	NULL
.	NULL

54	NULL
.	NULL

Lin	NULL
,	NULL
B	NULL
.	NULL

B.	NULL
,	NULL
Cross	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Halden	NULL
,	NULL
N.	NULL
F.	NULL
,	NULL
Roman	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
Toledano	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
and	NULL
Leonard	NULL
,	NULL
W.	NULL
J.	NULL
Delineation	NULL
of	NULL
an	NULL
enhancerlike	NULL
positive	NULL
regulatory	NULL
element	NULL
in	NULL
the	NULL
interleukin-2	NULL
receptor	NULL
-chain	NULL
gene	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
10	NULL
:	NULL
850-853	NULL
,	NULL
1990	NULL
.	NULL

55	NULL
.	NULL

Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Bohnlein	NULL
,	NULL
E.	NULL
,	NULL
Hoffman	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Bogerd	NULL
,	NULL
H.	NULL
P.	NULL
,	NULL
Dixon	NULL
,	NULL
E.	NULL
P.	NULL
,	NULL
Franza	NULL
,	NULL
B.	NULL
R.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
Activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
receptor	NULL
a	NULL
gene	NULL
:	NULL
regulatory	NULL
role	NULL
for	NULL
DNA-protein	NULL
interactions	NULL
flanking	NULL
the	NULL
«	NULL
B	NULL
enhancer	NULL
.	NULL

New	NULL
Biol	NULL
.	NULL

,	NULL
1	NULL
:	NULL
83-92	NULL
,	NULL
1989	NULL
.	NULL

56	NULL
.	NULL

Molitor	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Walker	NULL
,	NULL
W.	NULL
H.	NULL
,	NULL
Doerre	NULL
,	NULL
S.	NULL
,	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
a	NULL
family	NULL
of	NULL
inducible	NULL
and	NULL
differentially	NULL
expressed	NULL
enhancer-binding	NULL
proteins	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
87	NULL
:	NULL
10028-10032	NULL
,	NULL
1990	NULL
.	NULL

57	NULL
.	NULL

Kitajima	NULL
,	NULL
I.	NULL
,	NULL
Shinohara	NULL
,	NULL
T.	NULL
,	NULL
Bilakovies	NULL
,	NULL
J.	NULL
,	NULL
Brown	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
Xu	NULL
,	NULL
X.	NULL
,	NULL
and	NULL
Neren-berg	NULL
,	NULL
M.	NULL
Ablation	NULL
of	NULL
transplanted	NULL
HTLV-I	NULL
Tax-transformed	NULL
tumors	NULL
in	NULL
mice	NULL
by	NULL
antisense	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Science	NULL
(	NULL
Washington	NULL
DC	NULL
)	NULL
,	NULL
258	NULL
:	NULL
1792-1795	NULL
,	NULL
1992	NULL
.	NULL

58	NULL
.	NULL

Narayanan	NULL
,	NULL
R.	NULL
,	NULL
Higgins	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
Perez	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Coleman	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
and	NULL
Rosen	NULL
,	NULL
C.	NULL
A	NULL
.	NULL

Evidence	NULL
for	NULL
differential	NULL
functions	NULL
of	NULL
the	NULL
p50	NULL
and	NULL
p65	NULL
subunits	NULL
of	NULL
NF-xB	NULL
with	NULL
a	NULL
cell	NULL
adhesion	NULL
model	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
13	NULL
:	NULL
3802-3810	NULL
,	NULL
1993	NULL
.	NULL

59	NULL
.	NULL

Cerdan	NULL
,	NULL
C.	NULL
,	NULL
Martin	NULL
,	NULL
Y.	NULL
,	NULL
Brailly	NULL
,	NULL
H.	NULL
,	NULL
Courcoul	NULL
,	NULL
M.	NULL
,	NULL
Flavetta	NULL
,	NULL
S.	NULL
,	NULL
Costello	NULL
,	NULL
R.	NULL
,	NULL
Mawas	NULL
,	NULL
C.	NULL
,	NULL
Birg	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Olive	NULL
,	NULL
D.	NULL
IL-1	NULL
@	NULL
is	NULL
produced	NULL
by	NULL
T	NULL
lymphocytes	NULL
activated	NULL
via	NULL
the	NULL
CD2	NULL
plus	NULL
CD28	NULL
pathways	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
146:560-564	NULL
,	NULL
1991	NULL
.	NULL

60	NULL
.	NULL

Olive	NULL
,	NULL
D.	NULL
,	NULL
Ragueneau	NULL
,	NULL
M.	NULL
,	NULL
Cerdan	NULL
,	NULL
C.	NULL
,	NULL
Dubreuil	NULL
,	NULL
P.	NULL
,	NULL
Lopez	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Mawas	NULL
,	NULL
C.	NULL
Anti-CD2	NULL
(	NULL
sheep	NULL
red	NULL
blood	NULL
cell	NULL
receptor	NULL
)	NULL
monoclonal	NULL
antibodies	NULL
and	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

I.	NULL
Pairs	NULL
of	NULL
anti-T11.1	NULL
and	NULL
T1	NULL
1.2	NULL
(	NULL
CD2	NULL
subgroups	NULL
)	NULL
are	NULL
strongly	NULL
mitogenic	NULL
for	NULL
T	NULL
cells	NULL
in	NULL
presence	NULL
of	NULL
12-O-tetradecanoylphorbol	NULL
13-acetate	NULL
.	NULL

Eur	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
16	NULL
:	NULL
1063-1068	NULL
,	NULL
1986	NULL
.	NULL

61	NULL
.	NULL

Sambrook	NULL
,	NULL
J.	NULL
,	NULL
Fritsch	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
Molecular	NULL
Cloning	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
,	NULL
Ed	NULL
.	NULL

2	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
:	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
,	NULL
1989	NULL
.	NULL

62	NULL
.	NULL

Cerdan	NULL
,	NULL
C.	NULL
,	NULL
Courcoul	NULL
,	NULL
M.	NULL
,	NULL
Razanajaona	NULL
,	NULL
D.	NULL
,	NULL
Pierres	NULL
,	NULL
A.	NULL
,	NULL
Maroc	NULL
,	NULL
M.	NULL
,	NULL
Lopez	NULL
,	NULL
M.	NULL
,	NULL
Mannoni	NULL
,	NULL
P.	NULL
,	NULL
Mawas	NULL
,	NULL
C.	NULL
,	NULL
Olive	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Birg	NULL
,	NULL
F.	NULL
Activated	NULL
but	NULL
not	NULL
resting	NULL
T	NULL
cells	NULL
or	NULL
thymocytes	NULL
express	NULL
colony-stimulating	NULL
factor	NULL
1	NULL
mRNA	NULL
without	NULL
co-expressing	NULL
c-fms	NULL
mRNA	NULL
.	NULL

Eur	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
20	NULL
:	NULL
231-235	NULL
,	NULL
1990	NULL
.	NULL

63	NULL
.	NULL

Schmitz	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
and	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

The	NULL
p65	NULL
subunit	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
strong	NULL
transcription	NULL
activating	NULL
potential	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
10	NULL
:	NULL
3805-3817	NULL
,	NULL
1991	NULL
.	NULL

64	NULL
.	NULL

Suggs	NULL
,	NULL
S.	NULL
V.	NULL
,	NULL
Wallace	NULL
,	NULL
R.	NULL
B.	NULL
,	NULL
Hirose	NULL
,	NULL
T.	NULL
,	NULL
Kawashima	NULL
,	NULL
E.	NULL
H.	NULL
,	NULL
and	NULL
Itakura	NULL
,	NULL
K.	NULL
Use	NULL
of	NULL
synthetic	NULL
oligonucleotides	NULL
as	NULL
hybridization	NULL
probes	NULL
:	NULL
isolation	NULL
of	NULL
cloned	NULL
cDNA	NULL
sequences	NULL
for	NULL
human	NULL
B	NULL
;	NULL
-microglobulin	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
76	NULL
:	NULL
6613-6617	NULL
,	NULL
1981	NULL
.	NULL

65	NULL
.	NULL

Schreiber	NULL
,	NULL
E.	NULL
,	NULL
Matthias	NULL
,	NULL
P.	NULL
,	NULL
Muller	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
and	NULL
Schaffner	NULL
,	NULL
W.	NULL
Rapid	NULL
detection	NULL
of	NULL
octamer	NULL
binding	NULL
proteins	NULL
with	NULL
``	NULL
mini-extracts	NULL
,	NULL
``	NULL
prepared	NULL
from	NULL
a	NULL
small	NULL
number	NULL
of	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

,	NULL
17	NULL
:	NULL
6419	NULL
,	NULL
1989	NULL
.	NULL

66	NULL
.	NULL

Staal	NULL
,	NULL
F.	NULL
J.	NULL
,	NULL
Roederer	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Herzenberg	NULL
,	NULL
L.	NULL
A.	NULL
Intracellular	NULL
thiols	NULL
regulate	NULL
activation	NULL
of	NULL
nuclear	NULL
factor	NULL
«	NULL
B	NULL
and	NULL
transcription	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
87	NULL
:	NULL
9943-9947	NULL
,	NULL
1990	NULL
.	NULL

67	NULL
.	NULL

Bradford	NULL
,	NULL
M.	NULL
M.	NULL
A	NULL
rapid	NULL
and	NULL
sensitive	NULL
method	NULL
for	NULL
the	NULL
quantitation	NULL
of	NULL
microgram	NULL
quantities	NULL
of	NULL
protein	NULL
utilizing	NULL
the	NULL
principle	NULL
of	NULL
protein-dye	NULL
binding	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

,	NULL
72	NULL
:	NULL
248-254	NULL
,	NULL
1976	NULL
.	NULL

68	NULL
.	NULL

Olive	NULL
,	NULL
D.	NULL
,	NULL
Raymond	NULL
,	NULL
J.	NULL
,	NULL
Dubreuil	NULL
,	NULL
P.	NULL
,	NULL
Charmot	NULL
,	NULL
D.	NULL
,	NULL
Jacques	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Mawas	NULL
,	NULL
C.	NULL
Anti-interleukin	NULL
2	NULL
receptor	NULL
monoclonal	NULL
antibodies	NULL
:	NULL
respective	NULL
role	NULL
of	NULL
epitope	NULL
mapping	NULL
and	NULL
monoclonal	NULL
antibody-receptor	NULL
interactions	NULL
in	NULL
their	NULL
antagonist	NULL
effects	NULL
on	NULL
interleukin	NULL
2-dependent	NULL
T	NULL
cell	NULL
growth	NULL
.	NULL

Eur	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
16	NULL
:	NULL
611-616	NULL
,	NULL
1986	NULL
.	NULL

69	NULL
.	NULL

Zabel	NULL
,	NULL
U.	NULL
,	NULL
Henkel	NULL
,	NULL
T.	NULL
,	NULL
Silva	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
and	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

Nuclear	NULL
uptake	NULL
control	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
MAD-3	NULL
,	NULL
an	NULL
IB	NULL
protein	NULL
present	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
12	NULL
;	NULL
201-211	NULL
,	NULL
1993	NULL
.	NULL

